Content-Type: text/html
Reference sequence (query): batch____ Identities normalised by aligned length. Colored by: property
HSP processing: ranked Search cycle: 3
1 [ . . . . : . . . . 1 . . . . : . ] 162
batch____ bits E-value N 100.0% 1:162 MQSWYLLYCKRGQLQRAQEHLERQAVNCLAPMITLEKIVRGKRTAVSEPLFPNYLFVEFDPEVIHTTTINATRGVSHFVRFGASPAIVPSAVIHQLSVYKPKDIVDPATPYPGDKVIITEGAFEGFQAIFTEPDGEARSMLLLNLINKEIKHSVKNTEFRKL
1 UniRef50_Q01SW9 Transcription antiterminati... 164 9e-40 1 19.3% 2:162 66:239 -KKWYIIHTYSGFENKVQESLrdKIGQILIPTEEVVELRNGKKVTSKRLVYPGYVLVEMEMNDALWHEVKNTPRVTGFVGGGNSPVPLSADEVNSILYRqaERPRPKMTFEKNDSVRIIDGPFANFSGKVDEVNPErtLRVMVTIFGRATPVELEFLQVEKV
2 UniRef50_C7M2W0 Transcription antiterminati... 162 5e-39 1 20.8% 3:161 67:242 --EWYVVHCYSGYENRVRQNleDRIFEVEIPMEDVTELKNGRRVKVQRKVFPGYVLVRAEMDDEVWSAIRNTPGITSFVGSGSKPVPLSRKEVEAMFSFATPEELRPQpfEIGETVRVKEGPLADFVGEVAEVNADqkLKVLFNIFGRETPVELDFTQVSK-
3 UniRef50_Q6A6K1 Transcription antiterminati... 158 5e-38 1 21.2% 3:162 117:303 --EWYVLHTYSGMENKVKQNleDYIFETVVPTEEVVEIRNGARRTITRVYLPGYVLVRMDLTDDSWGIVRHTPSVTGFVGQSTTPIPLTFDEVVKMlsPKAKPKVEVADYEVGESVQITDGPFAGVPAQITEInnNQRIKALVEILGRSTPVDLEFNQIEKI
4 UniRef50_D1CD65 Transcription antiterminati... 153 1e-36 1 19.4% 3:162 29:199 --QWYVIHTYSGYEDKVKRDLqdRIRDIIVPTVEEIEIREGKRHKVQKKVFPGYVLVRMRMDDAAWNVVRYTPGVTGFVGSGTKPTPLDEKEVEKILQRMSEEPPKVKmlRLGEAVRIVDGPFTDFEGTVDEINEEkkVKVLISIFGRPTPVELDFLQVEKI
5 UniRef50_A5D5K3 Transcription antiterminati... 152 4e-36 1 21.7% 2:162 3:174 -KKWYVVHTYSGYENKVKANLEKRifRILVPMEDEVEIKDGKKKVSKRKIFPGYVLVEMIMTDDSWYVVRNTPGVTGFVGSGSRPIPLNDAEARQIIRQMgeEPRTRVDFTVGENIRVISGPFENFIGQIEEINMEkkVKVMISMFGRETPVELDFTQVEKI
6 UniRef50_A3EVT3 Transcription antiterminati... 152 4e-36 1 21.1% 2:162 11:184 -KNWYVIHTYAGFENRVKTSIEERVvqVVVPIQNVTELKEGKKKVSSRKVFPGYVLVEMEPTEEAIQFILATPKVTGFLGNGTTPIPMSSREVSELFDRIESGTAMpqHFSESETVRITDGPFQGFSGMISEVddHGKLKVLVSIFGRQTPVELDFLQVERL
7 UniRef50_Q1AU17 Transcription antiterminati... 150 2e-35 1 19.8% 1:162 1:176 MKKWYVVNTYSGHENKVRATLERRIeeIRIPTEQVIEIKNGKKVPTTHRQFPGYILVNVEMNDDTWRVIRQTPGVTQIVGSGDKPTPLSRAEVERLLHPEEPEKREkvDFDIGETVRVVAGPLSDFTGTISDIndQSKVKVLVSIFGRETPVELSFNQVAKL
8 UniRef50_D0LJE5 Transcription antiterminati... 150 2e-35 1 25.8% 3:161 18:188 --KWYVVHTHAGYEQRVRETLQQRAveILVPTLNVMEVVKGKRKTSTKKFFPGYIFVQMEFTDSVYHLIRNTPKVTGFVG-GNTPQPVPESEISVIHNTMSdkPRPKVMFEQGDNVRVTDGPFASFTATVEEVKPDkkLRVLVTIFGRATPVELDFTQVEK-
9 UniRef50_D0WPF7 Transcription antiterminati... 149 3e-35 1 23.3% 3:161 88:272 --RWYVLHTYSGYEKRVKQDLedYIFQIEVPMEEVFEIRRGQRKLVSRVRMPGYVLIRMDLTDDSWRVVQSTNGVTGFVGNGRTPVALSENEVVSMLTPvsPTPATLSPYAVGDAVTLTSEPWAGMPATVSEVdaNQRLTVLMTLVGQETPVELSFNQVRK-
10 UniRef50_B9KYX2 Transcription antiterminati... 148 5e-35 1 23.3% 3:161 27:196 --EWYVLHTYSGYENKVRQNlaDKVFEVVIPMQEEIEIRGGQRHTVQRKVFPGYVLVRMILDDESWHVVRNTPGVTGFVGVGNRPVPLDRAEAEaiRGAKAEQPKVRMTLLPGDVVRIIDGPFTDFRGVVDEVDNEkkVRVLVSFFGRETPVTLDFLQVER-
11 UniRef50_Q9CBK0 Transcription antiterminati... 148 5e-35 1 18.1% 3:162 38:228 --DWYVIHSYAGYENKVKANLETriFQVEVPTEEVTEIKNGQRRLVNRKVLPGYILVRMDLTDDSWAAVRNTPGVTGFVGATSRPSALALDDVVKFLLPSGSAKKdeVDYEVGESVTVMDGPFATLPATISEVNAeqKLKVLVSIFGRETPVELTFSQVSKI
12 UniRef50_P0AA01 Transcription antiterminati... 148 6e-35 1 16.9% 2:161 7:180 -KRWYVVQAFSGFEGRVATSLREHIkeVMVPTEEVVEIRGGQRRKSERKFFPGYVLVQMVMNDASWHLVRSVPRVMGFIGGtdRPAPISDKEVDAIMNRlgDKPRPKTLFEPGEMVRVNDGPFADFNGVVEEVDYEkrLKVSVSIFGRATPVELDFSQVEK-
13 UniRef50_Q9KGE7 Transcription antiterminati... 148 8e-35 1 19.3% 2:162 3:178 -KNWYVVHTYSGYENKVKTNLEKriFRVMVPVEEETEVKNGKSKQVSRKVFPGYVLVEMVMTDDSWYVVRNTPGVTGFVGsgSKPTPLLPEEVDAILRQMGMQEEreIDFQLKESVKVKEGPFANFIGTIEEIqdKRKLKVHVNMFGRETPVELEFTQIEKI
14 UniRef50_B4R8J9 Transcription antiterminati... 147 1e-34 1 19.4% 3:162 16:188 --KWYIVHAYSNFEKKVAESIREQAreILVPTEDVVEIRRGRKVNSERKFFPGYVLVKMEMTDEAYHLIKNTPKVTGFLGSGSKPIPVSEKEVERIVGAIEEGVERPKpfEIGEQVRVTDGPFASFNGSVEQVDEErrLRVTVSIFGRATPVELEYGQVEKI
15 UniRef50_C8XBG0 Transcription antiterminati... 146 3e-34 1 18.1% 3:162 123:306 --EWYVVHSYAGYENKVKTNLETRifQIEVPTEEVTEIKNGQRKQVQRKVYPGYILVRMDLTDQSWSAVRNTPGVTGFVGAtqKPSALTIDEVVKILTPTAPRKptEVDFSIGESVTVMDGPFATLPATINEVNAdqKLKVLVSIFGRETPVELSFSQVAKI
16 UniRef50_Q9CK84 Transcription antiterminati... 146 3e-34 1 20.0% 2:161 8:181 -KRWYVLQAFSGFEGRVATTLREYIkeVLVPTEEVVENVAGKRRKSERKFFPGYVLVQMEMNDETWHLVRSVPRVMGFIGGtdKPAPISQREADRILNRlsEKPRHRKEFQPGEEVRVTEGPFADFNGTVEEVDYEkrLKVSVSIFGRATPVELEFSQVEK-
17 UniRef50_P27309 Transcription antiterminati... 145 3e-34 1 21.4% 3:161 111:298 --EWYVIHTYAGYEKRVKANLEQriYQAEVPEEEIVQIKNGERKNVRQNKLPGYVLVRMDLTNESWGVVRNTPGVTGFVGNAYDPYPLTLDEIVKMLAPEAQEkiEVLDFEVGDSVTVTDGPFATLQATINEINPdkKVKGLVEIFGRETPVELSFDQIQK-
18 UniRef50_B0S060 Transcription antiterminati... 145 4e-34 1 21.2% 3:162 24:193 --KWYVVHTYSGHEGKVKVNIEKmiFEVVVPTEEYVSEVGGAKKLKERKIFPGYVFVKMTITDVSWYLVRNTRGVTGFVGPESKPVAVSEKEIQKFALKNQSYSKKEIDVNVGDNVNIVSGAFSDQVGIIEEINTEKAikVLISLFGRDTSVEISFDDIEKI
19 UniRef50_D2C1D2 NusG antitermination factor... 145 4e-34 1 71.6% 1:162 1:162 MRAWYLLYCKRGQLLRAKEHLERQDVVCLSPMIALEKIVRGKRTEVSEPLFPNYLFVEFDPEHIHTTTISSTRGVSHFVRFGNLPALVPQQVIEDLQHHQCTTHVDPETPQPGDQVTITEGVFSGLEAIYTEPDGEARSMLLLNLLNKQVRQSIDNRQFRKV
20 UniRef50_C1DDG1 RfaH n=1 Tax=Laribacter hon... 145 5e-34 1 31.7% 2:162 9:171 -MHWYLVHTKPRQEQCALQNLQQQGYQCYLPMLATEKLRQGRLVVSEEALFPRYLFIRLGlsDKSWAPIRSTRGVNQLVRFGTEPARIDDGLIERLRGHDAARANPEPLFRTGERVRLTDGPFAGIEGIYQMTDGESRVMVLIEFLTRPVVARVAPGSLRKV
21 UniRef50_Q0AUG6 Transcription antiterminati... 145 6e-34 1 16.9% 3:162 32:203 --DWYVVHTYSGYENKIkmNMQDKIFEVIIPEEQEVEYKNGKRKVTNKRIFPGYVIVNMIMDDDSWYVVRHTPGVTGFVGSGSKPIPLHQEEIDKIRRQMgeKKTMIIDIEIGESIRVKTGPFANFEGVVRELLPEkkIRVNISMFGRETPVELDYEQIEKI
22 UniRef50_D1NBR2 Transcription antiterminati... 144 8e-34 1 18.9% 3:161 14:191 --QWFVIHTLSGHENKVRDKILRqvYEAFIPTEKVAEVRQGKKTTTTRKLFPGYIWVRMDlnEKAWYFIRSVQGVLGFLGGDNKPTALTESEVEDIMRPAqpEVKPKIAFEVGEVVRIKDGAFENFEGAIQEIDNErkLKLMVSIFGRSTPVELEFWQVER-
23 UniRef50_Q5HRL6 Transcription antiterminati... 144 1e-33 1 18.6% 2:162 8:182 -KRWYAVHTYSGYENKVKKNLeeQIFRVVIPEEEETQVKDGKAKKLVKKTFPGYVLVELIMTDESWYVVRNTPGVTGFVGsgSKPNPLLPEEVRFILKQMgkEKTIDVELDVGEQVRIQSGPFANQIGEVQEIEADkkLTVLVDMFGRETPVEVEFDQIEKL
24 UniRef50_B8DVU5 Transcription antiterminati... 143 1e-33 1 18.8% 3:162 144:328 --KWYVLHTYSGYEKRVKSNIESriFQVEVPMEEVEKHTEKGKKVVTRVRVPGYVLIRMYPDENARRIVRETEGVTGFVGPSREPAPLSRKEVVSMMAPMIAShtLEVSYKVGDQVTVTDGPFTSMSAVVSDVEptQKLTVLVSIFGRDTPVELGFDQVQRL
25 UniRef50_A6FV14 Transcription antiterminati... 143 2e-33 1 29.3% 3:159 8:166 --RWYLVQFKPNSHKIAARNLQRQSFQTFLPMQDVTRRRAGKFHTAPQPLFPGYMFVSLDTIRGPWRQINATLGVSKLVSVAGRPQPVPDTLVNALLERCDDDGkpPETFSPGEQVTLRSGPFASFVATVEKMQPDRRVWVLLEFMGQATRIQVDADIL---
26 UniRef50_C4XIP4 Transcription antiterminati... 143 2e-33 1 13.8% 3:161 15:186 --RWYIVHTYSGFENRVELTLREmiKEVVVPTEKIIELVKGEKKTSTRKFYPGYVMVKMAMDDNSWHLVQSIPRVTGFIGGKNQPTPMRDSEAQKILSLmqEQPRPKYHFERGDDVRVIDGPFGGFNGVVEDVndKGKLRVSVSIFGRQTPVELDFVQVSK-
27 UniRef50_Q2LQ92 Transcription antiterminati... 142 3e-33 1 17.2% 3:159 4:173 --KWYVVHTYSGFESKVKQSLQERisDILIPEEDVVELVSGEKKTSKRKFFPGYILVKMELDDDTWHLVKDTPKVTGFIGSREKPSPIPDKDVELLKTRIDEgpKPKFKFEVGDHVTIIDGPFTNFDGVIDEVKAEkkLRVIVSIFGRPTPVELDFIQV---
28 UniRef50_P52852 Transcription antiterminati... 142 4e-33 1 20.1% 3:161 126:308 --EWYVIHTYAGYENRVKTNLedYIFQAEVPQEEVVQIKNGDRKTIKQNKLPGYVLVRMDLTNESWGVVRNTPGVTGFVGNAYDPYPLTLDEIVKMlaPQRKVEVQVLDFEVGASVTVTDGPFATLQTINEIKSDSKKVKGLVEIFGWETPVELSFDQIQK-
29 UniRef50_Q1WST1 Transcription antiterminati... 142 4e-33 1 23.6% 2:162 10:185 -KKWYVLHTYAGYENKVKENLESriFRVVVPEEEKHEtkTGKEKVEKLKTFPGYVLVEMVMTDQSWYVVRNTPGVTGFvgSGSKPAPLLDEEINHILHELGISSRHSNFdeVGDAVTIIDGAFSGLVGKITEIDTEkkLKVDIDMFGRETAAELNYDQVDKL
30 UniRef50_C8WBL1 Transcription antiterminati... 142 5e-33 1 18.6% 1:161 1:177 MSRWYIIHAYSGFENKVKEalQPLVEAIEVPTEQAVEVRRGKKVAVERKCFPGYVLAKLNMNEDVYHLVKNTPKVTGFLGFSGKPQPISDAEAEHILNHKAEAeqIKVDFEIGDQVKVLEGPFASFNGVVEDLddRARVKVSVSIFGRATPVELEFEQVER-
31 UniRef50_A4QBE9 Transcription antiterminati... 142 5e-33 1 20.1% 4:162 124:317 ---WYIIQCYSGYENKVKANleDDIFEVVVPIEQVTEIRDGKRKLVKRKLLPGYVLVRMDMNDRVWSVVRDTPGVTSFVGNEGNATPVKHRDVAKFLMPQekKPQVAVDFTVGEAVTILTGAFASVSATISSIDPeqKLEVLVSIFGRETPVDLSFDQVEKV
32 UniRef50_A6LPP9 Transcription antiterminati... 142 5e-33 1 19.4% 3:162 14:180 --RWYVVHTYSGYENKVKANLEKAIedIQVPMEEVVEEKDGKQKVSLKKKFPGYVLVKMLMGDEAWYVVRNTRGVTGFVGPGSKPVPLSDEEVESMGVLE---VPVEIDLEVGESIRIISGPLRDSVATIQEIIPDKrvKALVEMFGRETLAELDFNQVEKL
33 UniRef50_C1Z9H7 Transcription antiterminati... 142 5e-33 1 20.6% 2:161 29:203 -MLWYVLKITSNREKSIRDNLLRRIreILIPTEKVVENKNGKKKVVEHKLYPGYLMVQMILNDDTWYIVRTTGGVGDFTGSAGKPTPMQDHEIARMLQKQEQKQemKIEFAVGDIVKIKEGTFEGFEGPIDSIDenGKINVLVEIFGRSTPVELEYWQAER-
34 UniRef50_A4WZX9 Transcription antiterminati... 142 6e-33 1 31.6% 4:161 13:172 ---WYLVQTKPNAFRIAERNLLRQDFSVFSPTQNQTKKHGTRFRHTVQQLFPGYLFVRFNPEFPQWRAINATYGVSRLVTFGNIPSPVPHALIAGLRQRCANDGtpPEQLSLGDRVRIISGPFADYVATVEQIEPDKRVWILLDILGGQTKTQIQIAALQK-
35 UniRef50_C7RAP1 Transcriptional acivator Rf... 141 8e-33 1 41.2% 2:161 6:166 -KSWYLINSKPKQELRALEHLKNQEINCVLPVLEVERIIRGKRQKAIEPLFPGYLFVELQTNGQGWSKIRSTRGVRDFVRFGGVPGRVPDSVLEHLLILDTSFTPIETnpGAGDKVIITDGPFKDLEGVFKISNGEKRSIVLLTILGKVTEMELENKQLRK-
36 UniRef50_D1BP79 Transcription antiterminati... 141 8e-33 1 21.9% 2:161 5:176 -KKWYVIHTYSGYENKVKTTLELkiSRILVPLEDEIDEKDGVKKVVKRKIFPGYVLVEMEVNDRSWYVVRNTPGVTGFVGSATKPVPLSDSEVEHILKslDKKPTINVDVEVGETVRITSGAFEDKLGVITELNPEktLKLSVEMFNRDTEVELEFSQVEK-
37 UniRef50_C8NX40 Transcription antiterminati... 141 9e-33 1 18.1% 3:162 145:341 --SWYIIQSYSGYENKVKTNleESIYDVVVPIEQVFEkkNGKKKIVKRKLLPGYVLVRMDLNDAAWSVVRETPGVTSFVGNEGNATPVKHRDVAKFLMPkeEKPNVAHDFQVGEAVTILSGALASVSATINEIDPegKIQALVSIFGRETPVELTADQIERI
38 UniRef50_A9ND88 Transcriptional activator R... 141 1e-32 1 32.5% 3:159 6:164 --DWYLIYTKPRQERIAEENLERQGYRIYLPFIQVNRRRLGCYQLITEPLFPRYLFILLNIDKDNWGPIRSTRGVSALVRFGGIPAKVPPDFVQFLKNNeaSVPPKVSLFQKGQRVQIIDGVMAGYEGVFEMYSGAKRVTLLLDMVGKVTRVEVPLDSV---
39 UniRef50_B0RIR6 Transcription antiterminati... 140 1e-32 1 20.0% 3:162 157:345 --KWYVIHSYAGFERRVKSNIENriYQIEVPMEDVVEIKNGQRKMVNRVRIPGYVLVRMALNEDSWSVVRHTPGVTGFVGNAHNPTPLRFEEAFSMLkqAQRVVAAEVDFEIGETITIKEGSFAGLPGSISEIKPegKLTVLVSLFERETPVELSFDQVTKL
40 UniRef50_P35872 Transcription antiterminati... 140 1e-32 1 22.6% 3:161 4:183 --EWYAVHTLVGQEEKAKANLEKRifQVLIPTEEVVELrgGKKEVVRKKLFPGYLFIQMDLGDEewEVVRGTPGITGFVGAGMRPVPLSPDEVRHILEvkKEAPKAQVAFREGDQVRVVSGPFADFTGTVTEINPErkVKVMVTIFGRETPVELDFSQVVK-
41 UniRef50_B3QYK9 Transcription antiterminati... 140 1e-32 1 18.4% 3:160 29:199 --RWYTVRTYSGHERKVKEHLDKKIDdvYIPYERFVEVKDGKKKSRVKNAFPGYVLIEAVLDKQTRYLVLDAPSVIGFLGVGDEPTPLRPDEVKRLLEPEQEIevTKAPFEVGGAVKIIDGPFNSLTGVIQEVNAEkkVKVLINFFGRSTPTEVDFSQVK--
42 UniRef50_A3WUF1 Transcriptional antitermina... 140 2e-32 1 25.3% 3:160 7:168 --QWYVVQTHPHAEGKAAAHLRRQGFEVYLPRYARRRRHARRVDITASPLFPRYLFVAIDLVHQRWRAIRSTVGVTNLVYSGDEPAPVPDDVVRRLKQREDSKGCVqpRFSAGDTVRVVDGAFSDCLGLFESMSDGERVLVLLDLLGRKVRVTMDIDTIE--
43 UniRef50_A6F1J5 Transcriptional activator R... 140 2e-32 1 35.6% 2:161 1:159 -MTWYALQHKPSQGDRALTHLQNQDIACFYPKITVEKIKAGKRTKQLEPLFPGYLFVNLEQTDPMWAKLRSTRGILRIVSFANKPAAIPDDVIQHIKDSLHTVAEQG-GIKPGQAVELDEGPFKGIEAIFQAYDGEERAIVLISFMQKQQTVKVPLSTLHR-
44 UniRef50_Q0ACI7 Transcription antiterminati... 140 2e-32 1 32.9% 2:162 13:177 -RAWYLIYTKPRQEEAARDNLGRQGFHAWLPRVRVVKRRGTRRVPVVEPMFPRYLFVELDSAYQDWSPISSTLGVTSLVRFGGVPAKVPGPLVAALQARADEDDiaRQQPRAGDTVRVAHGAFAGYEAVFQARSGRERVLVLLEVAGKQSRVTLPADDIDPV
45 UniRef50_C4Z2Q9 Transcription antiterminati... 139 3e-32 1 21.5% 3:160 5:176 --KWYVVHTYSGYENKVKANIEkqILEVIVPLETVVEIKDGSKKAAQKKMFPGYVLVKMVMNDDSWYVVRNTRGVTGFVGPGSKPVPLTPTEIKNLGISLEEEQEVKPVikVGDKVMILSGAWEDTVGEITNINEGKqlTINVEMFGRETPVEIDFTDVK--
46 UniRef50_C7RDB1 Transcription antiterminati... 139 3e-32 1 20.6% 3:162 40:207 --RWYVVHTYTGYENRVNDKIQMMilEVTVPTEEYVEVKNDTKKVKTRKLFPGYVMVKMNITNKSWYIIRNTQGVTGFVGPDGKPVALTPAEVRKF-GVKDEAPILNINVNVGDDVNIISGPFEGFVAKVEEVDKEKgiKAFVDMFGRDTLIDLDFTDIETI
47 UniRef50_B1I1L1 Transcription antiterminati... 139 3e-32 1 19.9% 2:162 3:177 -KQWFVVHTYSGYENKVKANLEKRifRIVVPVEDEIEVKGGKRKISKRKIFPGYVMVEMILDDDSYRVVRNTPGVTGFVGsgSKPIPLTDAEANQIiqMEGDEPRIRIDLVPGEKVRVMAGPFENFIGTVDDVNYEkkIRVMISMFGRETPIELEYFQIEKV
48 UniRef50_Q82X31 Putative transcriptional ac... 139 4e-32 1 35.6% 2:161 1:163 -MHWYLVHTKPKQEKCAFQNLQQQGYRCYLPMLPVEKLHLGNLTVVDEPLFPRYLFIQLEQGdkSWVPIRSTRGVNRLVCFGSEPARIDDILIDLLRMQEAsqHKPERLFKPGERVRLTEGAFAGIEGIYQMAEGERRVMVLIELLSKPVAMRVSPTSLRK-
49 UniRef50_Q4K6G2 Transcriptional activator R... 139 4e-32 1 34.6% 4:162 84:239 ---WYLVQCKPRQDLRAEENLRRQGFHCYRPQRGCERVVQGRRQSGTESLFPGYLFIALEH-DASWAPLRSTRGVNRLVAFNGQPLAVPVSLIESLRQRVTDMDTSLPY--KGTRVCITEGCFADLEAIFESSIGDERVVLLLTLLNQQRRIELPLSSIRKI
50 UniRef50_A6W3A4 Transcription antiterminati... 139 4e-32 1 16.9% 2:161 3:176 -KRWYVVQAYSGYEKHVMRSLIERVqdILVPTEEVVEIRDGKKRKSERKFYPGYVLVQMDMNDASWHLVKGTSRVLGFIGGtdKPSPITSREADAILQRVSDgpRPKTLFEVGEVVRVNEGPFADFNGVVEEVDYDkrIKVAVLIFGRSTPVDLEFSQVEK-
51 UniRef50_C4LL90 Transcription antiterminati... 138 4e-32 1 20.0% 3:162 154:352 --EWYIVQCYSGYENKVKTDLeeQIHEVVVPIEEEVEVKDGKRKVVKHKLLPGYVLMRIELDDASWSVIRDTPGITSFVGNEGHPTPVKIREVAKFLLPPesADKVKVDYEVGEAVTVLSGPFASVSATISEIDAEnkLKALVSIFGRETPVELDFDQVEKI
52 UniRef50_A0KGQ9 Transcriptional activator R... 138 4e-32 1 42.0% 1:162 18:182 MKKWYLAYCKPKEEARARAHLEAQGIESYYPMVEIEKLRRGKRVPVREPMFPNYLFIYVDLEEVTPVTLKSTRGISRIIHFGREWTSISSQLVYQLMSRDDSDEARASypTQGDKVLIESGPLAGFEAIYLEPDGDKRAILLVSLLNQETSSSFDNQSFRRL
53 UniRef50_D2RNN9 NusG antitermination factor... 138 5e-32 1 18.6% 2:162 5:190 -KHWYVIHTYSGYENKVKMNLeeQIFQVLVPMQNEVDAKDDKQKVVARKVFPGYVLIEMIVDDRTWYAVRNTPGVTGFVGTGTKPIPLSDREVERIlaVEEPVVRMECPVGLNDTVRIKAPGFTDMVGTVAEINDeqKIKVMVEMFGRETPIEVKFTQVEAI
54 UniRef50_Q7MMR1 Transcription antiterminato... 138 5e-32 1 45.0% 1:160 1:165 MKKWYLLYCKRGEQIRAKQHLENQGVECFYPTIEVEKILRGKRQIKSEPLFPSYIFVRFDFegPTFTTVRSTRGVVDFVKFGAHPKELQGDLIYELKLLEQEGHQssNLPKPGDSIKVKSGQFAGIEAIFQEQDGETRSIMLVKMISQTVPVSIENSDLE--
55 UniRef50_D1B6U2 Transcription antiterminati... 138 5e-32 1 20.5% 2:162 6:180 -RRWYIVQTYSGYENKVKANLEQRifNVLVPVEEKVFVKEGRAKRVRRKVFPSYVLVEMIMDDQSWYVVRHTPGVTGFVGSGNHPIPLTDREVakIGLPADRKPKVELDIEVGDTVRVKSGPFEGCVGPVVEVDPDkrVRFSVTVFGRETVAEAGHEDLEKV
56 UniRef50_P0AFW1 Transcriptional activator r... 138 6e-32 1 100.0% 1:162 1:162 MQSWYLLYCKRGQLQRAQEHLERQAVNCLAPMITLEKIVRGKRTAVSEPLFPNYLFVEFDPEVIHTTTINATRGVSHFVRFGASPAIVPSAVIHQLSVYKPKDIVDPATPYPGDKVIITEGAFEGFQAIFTEPDGEARSMLLLNLINKEIKHSVKNTEFRKL
57 UniRef50_C2KN14 Transcription antiterminati... 138 6e-32 1 19.4% 3:162 90:279 --RWYVVHTYSSYEKRVKQNIEQriYQVEIPMEEHIEVKAKSRRKVLRPRIPGYVLVRMDMEENSWRLVKDTPAVTGFVGNQQDPVPLTLQEVIDMLAPTAAQaqIVTDFEVGQGVTITSGPFETMTATIAEIYPdsKLKVLVTIFERETPVELNFDQVEKI
58 UniRef50_Q1UZH8 Transcription antiterminati... 137 1e-31 1 16.8% 1:161 1:174 MKNWYIVQSHSNFENKVAGLIKekIEEIVVPTHDVTEVKRGKRIQRKKKYFPGYVLIKSEMDNDLYHLIKNLKRVSGFLGSKGIPVPVSDKEIEKILGQIKDGVAQpiEYSIGEKVQVVDGPFASFSGMVEDIDEEkrLKVSVSIFGRPTPVDLEYNQVEK-
59 UniRef50_P57151 Transcription antiterminati... 137 1e-31 1 15.6% 2:161 7:180 -KRWYVLQAFSGFESRVAQSIREHVkeVMVPSQEVVEIRGGQRRKSEYKFFPGYVLIQMKMTDSTWHLIRNVPKVLGFIGgsDKPSPISDKEVEIIINRlgNKPRPKTLFEPGEMIRVNDGPFADFNGVVEEVDYEkrLKVSVSIFGRSTPVELDFRQVEK-
60 UniRef50_Q1QVL5 Transcription antiterminati... 137 1e-31 1 35.2% 3:161 18:180 --RWYVVQCKGGESFRAGEHLTNQGYRVFHPVLEVQKKRRNKLVWIAEPLFPHYLFIHLDRVASNWRPIRSTRGVLKLVGFGDEPLPVPDALIETLAARAHLDEASRtyFRPGEIVEITEGPFQALQAVFDTQQGDERAIVLLNMLHHQQRLELPVGHLRR-
61 UniRef50_B2KEU4 Transcription antiterminati... 136 2e-31 1 18.6% 2:162 5:177 -KAWYIVHTQTGHEDKVRenFGDRIFQVLVPTEDVVEVKQNKKVQRKRKFFPSYVLVEMDLTSEAYWFIRNVSGVTGFLGDPN-PVPLPEEEIAAIlqPGSGKPKHVIEFEAGENVRITEGPFKHFIGVVQEVNNQkkLKIMVNVFDRSTPVELDFLQVEKI
62 UniRef50_D0MHN6 Transcription antiterminati... 136 2e-31 1 19.9% 1:161 10:184 VRKWYVLRTFSGHEKKVKQYLEREIeqILIPTETVFELRGGKKRTRERTFFPGYILIEAVLDRELQHLIANMPSVVGFLGSGDQPTPLRPDEVRRILGKVDegEQPEIPFKPGDVVRIIEGPFNNFTGVVEEVYPDkkLKVMVSIFGRKTPLEVDYLQVER-
63 UniRef50_C9M8Z2 Transcription antiterminati... 136 3e-31 1 22.5% 3:162 12:185 --QWFAVQTYSGYENKVKNNLEQRifRVLVPMEDVVVVKDGKSKQMSRKLFPSYVLVEMIMDDQSWYVVRHTPGVTGFVGAGAHPLPLSDEEVRDVLVkeAETPQIVVECQVGDSVRVKSGPFVGAVGVVSDVNTsgKVKFVLSVFGRETEAEVNHTELERV
64 UniRef50_Q48H23 Transcriptional activator R... 135 4e-31 1 33.8% 3:162 9:166 --RWYLIQTKPRQEARAEEHLRRQHFQCYRPLQ-VDVKKTAARVQADEPLFPGYLFIQMDQVQDNWYPIRSTRGVSRIVTFGGHPVPVRDHLIEQIRQRLST-PAPKARFIQGDPVMITTGSWSDVEAIFLSEDGTERAVILLNMLQRQQKMGLPISSLSRV
65 UniRef50_A0Q872 Transcription antiterminati... 135 4e-31 1 16.9% 2:161 1:175 -MLWYVVQVHSGYEKRVKAQLEENIerILVPTENVVEMKGGQKRKSERKYFPGYVLIEADLSTDAWNLVKSVPRVLTVVGSKGKPIPLSKAEVDRILGFVEgePRLRKSYHVGEVVRVLEGPFNDFTGVIEEVNYEkrLRVAVSIFGRSTPVELEFSQVEK-
66 UniRef50_Q1YPV4 Transcriptional activator R... 135 5e-31 1 42.1% 1:159 1:161 MESWFLLQTKSKQEGRAVENLERQGVKSFCPMIKVEKLSRGSRVVKEEALFPGYLFVNFDQSSVSSTTVRSTRGVSHFVTSAGLPVKVPESLINQLMLRTdnDETVSSLPSKGERLQIIDGPFRGLNAVFSQPDGDRRAIVLINLLNQQVSASLPFASL---
67 UniRef50_C9LQP9 Transcription antiterminati... 135 6e-31 1 19.9% 3:158 35:200 --RWYVIHTYSGYENKVKDTLTRkiIQILLPMHDEEEVKDGEKKVVSRKVFPGYLLIQMEVNDRSWYVVRNTPGVTGFVGTTTKPIPLSDEEAKRIIEGKDKKQTAKTDAKVGDTIKITRGPFADRSAVVLDvdDRSKIKADISNFGTTTTIELEVGY----
68 UniRef50_A1WZB7 Transcription antiterminati... 135 6e-31 1 29.1% 4:161 15:174 ---WYLVYSKPRQEERAWWNLDHQGFRCFLPMARFRRRRQRRYQTVIEPMFPRYLFIRLAAGLEDWSPIRSTTGVSGLVRFGTWPARVPDGLVDTIRARIEDGHCdpEPLQPGERVRVLDGPFQSYEGIFRASRSDERVMILLDVAGQHTTLTVSQHQIER-
69 UniRef50_B1I6V9 Transcription antiterminati... 135 7e-31 1 24.4% 3:162 4:168 --QWCAVNTKPKKEDFAARQLEAKGLEVFLPRISVTRKRGASKFSLWEPLFPGYLFVKLLPEPVQVQRVNWTPGVRRLLCAGDTPVPVPDEAIALIRQRVGPgpKPQAEFPAGSRVAVRHGPFAGLLGVVEkmSGRGRVRVLLELLQRQTAVEIDAVDLDRL
70 UniRef50_P65591 Transcription antiterminati... 135 7e-31 1 18.6% 2:162 3:177 -KKWYVVQAYSGFEKNVQRILEERIaqILVPVEKVVDIRNGRKTISERKSYPGYVLVEMEMTDDSWHLVKSTPRVSGFIGgaNRPTPISQREAEIILQQVqeKPKPKVEFEVGQQVRVNEGPFADFNGVVEEVNYErkLRVSVQIFGRETPVELEFSQVEKI
71 UniRef50_A6CA55 Transcription antiterminati... 134 8e-31 1 18.2% 4:162 22:194 ---WYVLKVQSNREKSIRDALLRGIkeIIIPTEKVVETKGGKKRVFERKLYPGYLMIQVELNDDSWYLVRSTNGVGDFTGAAGKPIPMQEHEIARMLGREESKEETPvdFQVGDVVKVKDATFEGFEGTIDAVDesGKVTVLIEIFSRPTPTELEYWQIEKV
72 UniRef50_Q1RHC5 Transcription antiterminati... 134 8e-31 1 20.0% 2:161 18:188 -KKWYVIHTASGAENRIKRIMLERIsdILVPVFGVSEVKRSKNVKVEKKLMPSYILIKMNMTDKSWHLVKNIPGVTGFLGSKTTPKALTESEIQNIRLETEAKEAKDAkyEVGEIVTVTEGPFETFTGTVEEVDQEkrLKVSVSIFGKATPIELSFTQVKK-
73 UniRef50_B9CLA2 Transcription antiterminati... 134 1e-30 1 15.2% 2:159 3:180 -KRWYVLHTYSGYENKVMNDLedAVVDVQAPGEMVTEVKKRGEKDveVKFYPGYVLVRMELDDNTWSVVRNTPGVTGFLGVDGKPSPLRREEFNKMMRRSGGkkRVTTDVEVGQSVHVLSGPLADFDGIVSEVNAegKIKVMLTIFGRETPVELTLDQI---
74 UniRef50_C1A6N2 Transcription antiterminati... 134 1e-30 1 23.4% 3:160 5:179 --RWYAIQTTSGHENKVQRLIQRKirQALVPTQQVVEIKNGKKVTVERKIFPGYVLVEMVASQDTLHEINAIQGVIKFVGKDKDPMPLRDDEVRRLLGQADPADETPvpFLVGQAVAITEGPFADFNGTVEEILPDkkVRVSVSLFGRPTSVELDYLQLR--
75 UniRef50_Q9ZK20 Transcription antiterminati... 134 1e-30 1 18.5% 1:162 1:175 MMDWYAIQTYSGSEQSVKKAIEnrIQEIIVPTEDIIEvkKSKTKVMERSLYPGYVFIKVDLDTVLWHKIQSLPRVSRFIGENKKPTPLSEADIGHILEKMNNrpKPKIFFEQGEVVRVVEGPFANFTATVEEYdeHRKLKLNVSIFGRTTPIEILYSQVEKI
76 UniRef50_A3ZLI3 Transcription antiterminati... 134 1e-30 1 18.0% 2:162 118:294 -MDWYILKVQSNREKSICANLWRRVkeVMVPTEDIVEFKNGKKKITKRKLYPGYIVVHMAINDDTWFLVRETGGIGDFTGAAGRPTPMLAHEVERITKKVEDEETGEEpfKLGDHVRITEGTFENFEGDVEGIDenGRVTVMINIFGRTTPVEMEHWQMEPV
77 UniRef50_Q9CDV7 Transcription antiterminati... 134 1e-30 1 23.9% 4:162 13:183 ---WFVIQTYAGYERKVKEDLLEriLRVEIPTETIRTEVNGKMKEVEENLFPGYVLVEMNMTDEAWFIVRNTPNVTGFVGSHgkPTPLFEQEIQDILVGMGKVVREIDfvFVGKRVRIVDGAFSGFEAPITEINGDK-LTLTVDMFGRATPVELDMHQIEDI
78 UniRef50_Q83MQ7 Transcription antiterminati... 133 1e-30 1 20.8% 3:161 36:215 --KWYVVHSPAGFERRAKANLeqAIYQVEVPMEDVVGIRNGQRKMITRVRIPGYVLVRMDLNESSWAVVRNTPWITGFVGNMHQPVPLSFEEVFDMlrQKRSVTVSDVDLEVGETVVIKTGSFAGLPGTISEIKPegRLTVLISLFERETPVELAFDQVEK-
79 UniRef50_Q2WBC3 Transcription antiterminati... 133 2e-30 1 25.6% 1:160 1:164 MESWFVVHTHANAEKIAAGHLQRQHFDVYLPQYSKRRSHARKVEWVKAPLFPRYLFLRMDPDLTPWFSIRSTVGVHSLVCRGGMPVPLGQVIIDEIRGREDDSGLVsmPFASGQRLEIVEGPLAEQLGLFQGLDDMNRVVLLLDLLGRQVRVRVPLEAVR--
80 UniRef50_A4XLK3 Transcription antiterminati... 133 2e-30 1 22.0% 3:161 7:174 --KWYVVHTYCGYENKVKANLEkkILDIRIPTELVTEIKDGKKIVKEKKKFPSYVLIKAVMDNDIWYTIRNVRGVTGFVGPESKPTPLTDEEIEAM-GIKEEEVVEVFDIEVGDNVKIVAGPFADFYGPVIDINKekKVKVMLNLFGRETPVEFDYHQVEK-
81 UniRef50_B3EL56 Transcription antiterminati... 132 4e-30 1 14.4% 3:162 19:191 --RWYALRIYSGHERKVKeaLEDKILQVYVPYEKFVEVRNGKKRSLTKNAFPGYVLIEAILDKQTKNLIMDIPSVMGFLGVNDIPTPLRPDEVEKILEPESTVEQreAPFRVGDTVKVIDGPFSSLTGVVHDVceRMKVKVMISFFGRSTPTELDFSQVKSI
82 UniRef50_Q0FE68 Transcription antiterminati... 132 4e-30 1 25.2% 2:160 3:163 -KEWFILQFKPNSHHQATKNLTRQGFETFLPLTDITSRKTSRFINTTRPLFPGYMFITFDRTKPEWHKINNTYGVSRLVTFNSNLKSIPTTLVENLMVRCdsKILPVENLKKGDQVKILHGPFANFIATVETYETDQRIWVLMDLMSRKTKIQTPLDALE--
83 UniRef50_Q3J8A9 Transcriptional activator R... 131 5e-30 1 35.4% 2:162 9:172 -KFWYLIYCKPRQERLAQENLERQNFETYLPLVRQMRRRAYRRIATVEPLFPRYLFIHLDTEKDNWGSIRSTIGVISLVRFGAQPAHVPDTLIRELQTHEGSddLASPDFRKGQQVLVEEGLLAGHEGIWLTSNGKKRAHILLEIMGKQIKTEVNENWLKRL
84 UniRef50_Q6AP83 Transcription antiterminati... 131 5e-30 1 17.7% 2:159 3:174 -KQWYILQAHSGFEEKVKLTLEDRIkdILVPTEQVVEMVKGSRKTSSKKFFPGYMLINMELTDETWHTveNMPRVVGFVGDDRNPMPLSDEEAAKIIGRIQEgpRPKVIFDVGENVRVIDGPFSNFQGVVDEVFPDkrVRVMVSIFGRETPVELEFVQV---
85 UniRef50_Q3KCF2 Transcriptional activator R... 131 6e-30 1 32.1% 3:161 10:169 --NWYLLQCKPRQDERAHLNLLQQNYVVFHPQLVSERVIRGKRQRVQESLFPGYLFIQLSR-DDNWAPLRSTRGVSRFVEFNHGPATVAEHVIEHLRARCLESTLSEPdlKPGENLQIVSGPLAPLEGVFLGLHGTDRVMILLQFLNREQPVCLPLSVIER-
86 UniRef50_B2UQY7 Transcription antiterminati... 131 6e-30 1 18.1% 2:161 9:188 -EQWYVLHVLSGQENSVRDRIIRkiYRVEVPTELISEVRNGKKTERHSKLFPGYVYANmtLNKDLWYFIQQIDGVISIAGSRNAPLPMRKREVEDLLPLLDAEAvpKVEFAVGDPVRVCEGPFQSQEGTIEEIDPEkkLRVSVSIFGRATPVDLEYWQVEK-
87 UniRef50_D2R5P4 NusG antitermination factor... 131 7e-30 1 16.2% 3:162 91:267 --EWYILKVQVNREDSIKASLLRRikDVVVPTEDVAetKTGKRRVVKKKIYPGYILVNMVFNDETWFIVRETSGIGDFTGAMGKPTPMDPKDVERILRSSknQVRTAIPFKVGDRVRVKEGYFQNFEGDIDGIdaNGRVTVMINIFGRSTPVELEHWQIEAV
88 UniRef50_A1T084 NusG antitermination factor... 131 7e-30 1 39.4% 3:162 4:167 --QWFVVYCKSREELRAQRNLENQGVYSFFPKICKEKILRSKKKVVEEPLFPSYLFVNISKNDEKFSAIRSTRGINNFVKFGLSIATIPDQQIKKIEQLCHVnvNSEDVYQNGDKIEILSGPFKGLTAIFNIEDGLERSMLLLKILNQDNNISFKNSALKKV
89 UniRef50_Q2LVW1 Transcription antiterminati... 131 7e-30 1 19.9% 2:162 1:167 -MSWYAVHTRSRHEDKVFTGLVQKSITTFLPKIEVWSKRKDRRKRIMTPLFPGYLFVDMplDNQAKLDVLKTFGVVRILgtGSAPIPVPDDKIDAIRRIVDseVQNLQYPHVGEAARIVDGPFKGIEGTVIKTDYDKDlvVTIELLQRSVAIKLDSSQIEKI
90 UniRef50_B1KMD8 Transcriptional acivator Rf... 131 8e-30 1 32.1% 1:162 3:179 MKAWYLLYCKPRGEARAVHNLTLQNIDTYLPTIGEEKRVKGEVSIKRIPLFPGYLFINIDPQVTSVARIHSTRGVGRIVGCNELMTSIDDSIIHSIRLREHkdGSSTVEINPGDQVKFTEGPFADLEGIFAEKSGDKRCHVLFEIMGQKKRVSVPRDSIKPV
91 UniRef50_B1ZPC3 Transcription antiterminati... 131 9e-30 1 20.1% 3:161 12:189 --QWFALHTLSGQENKVkeELDDSIFEVLLPTEIVSEVKGGKKSTKVRKLYPGYVFIQMRLYGEdwYFVKEVAGVIGFVG-GDRPAALRQSEIDEIRARIegKEVPKVQYSVGEEVKITDGAFASLTGRIDEIDPErkLKVSVSIFGRFTPVELEYWQVQR-
92 UniRef50_A0XZ39 Transcriptional activator R... 130 1e-29 1 39.4% 1:160 1:159 MESWYLVICKPRQEERAKANLNNQGIEAFYPILTTEKLVKSRRTVKQVALFPNYLFVCLDSKNGPFAAVKNTRGIGGFVTYGANYQVVPLAIIEHLNNHTSNTVESQL-PKQGDAVSVSNHSFKNIDAIYKEPDGDMRSILLINLLNKQVEMSVDNTDIE--
93 UniRef50_B8FH43 NusG antitermination factor... 130 1e-29 1 18.9% 2:160 10:169 -KQWYALYTKSRHEACVNNYLAARSIESFYPQMRILSRRKDRRKMIDVPMFPGYLFVRAALRSRQHLSILKAPGAVTLIGNTRGAIAIPEDTISSLRIVSQKEALEtpCYHAGDLVLIVSGPFAGVTGVFMRNKGGGKILVNIDALGQSVAVEMGGADVQ--
94 UniRef50_A7BC06 Transcription antiterminati... 130 1e-29 1 18.1% 3:162 72:254 --DWYVIHTYSGHERKVKANLEQRifAVEVPDEYVMEYRGNAKKRVRHVRIPGYAIVCMDFNEASYRVVKETPAVTGFVGDQHNPVPLSIDEVVMLLTPNVLEEAAetQFEVGEIVTVTDGPFETMSATISEIMPeqKLKVLVTIFERETPLELGFDQVEKL
95 UniRef50_P68893 Transcription antiterminati... 130 1e-29 1 22.2% 2:159 7:176 -KGWFVLQTYSGYENKVKENLLQriLRVEIPTQTVNVEKNGQTKEIEENRFPGYVLVEMVMTDEAWFVVRNTPNVTGFVGSHgkPTPLLEEEIRAILLSMGqiDVFDTNIKEGDVVQIIDGAFMGQEGRVVEI-ENNKVKLMLNMFGSETVAEVELYQI---
96 UniRef50_B3E158 Transcription antiterminati... 130 1e-29 1 18.8% 2:161 21:199 -MQWYALHVLSGQEEKVKKNLEKRIkeVVIPVERVSEVRKGKRIEINRKLYPGYVFLQIQLRdrAWYFVRETSGVIGFA-DGDNPLPMPREQVEGMLRQIQesALPKTVFSVGDRVKVGDGPFLNSEGVIEEVdeRGKLRVSVNIFGRSTPVELEYWQVEK-
97 UniRef50_Q14PQ9 Transcription antiterminati... 130 2e-29 1 18.8% 3:162 32:216 --KWYVINCYSGHEDRVRDDLIQRvfDIRVIKETVSAKKGGKLIEKEKNLYPGYIFINMIMNDEAWYIVRNTTGVTGFIGSSgkPFPLTDQEARTMLSkkKVKKVFVANFEVNDYVRILSGTFTEMEGQVTKIDTSKGIavNLEMFGRLTPTEVEFDQCEKI
98 UniRef50_Q6MJ02 Transcription antiterminati... 130 2e-29 1 18.8% 2:161 3:176 -KKWYIVNVQTSCENTAKKAIEEKIkeILIPAESVVELVKGQKQTKSRKFFPGYIFVQMFLNDETWHLVRNSSKVTGFVGGTkrPPEVPEAEVLRVTQQmaEKPRPKVKFAVGENVTVIDGPFSNFQGTVEEINEDkkLKVLVSIFGRPTPVELDYIQVEK-
99 UniRef50_A0LIY4 NusG antitermination factor... 130 2e-29 1 17.6% 2:160 39:200 -KSWFALYVQVKHEKEVVRRLDQKSIDCFLPLMECWSKRLDRRKRITLPLFPGYVFVHTVLDNYTNVNILKTPGALSILKNSEGPLPIPVYQIENLQTILNSSKslHPYLKEGEWVRVIRGPLSGCVGILKRHAPKkrLVVSVDCIRQSVSVELDVEDVE--
100 UniRef50_D2MPP9 Transcription termination/a... 129 3e-29 1 17.5% 3:162 19:193 --RWYVVNTYAGHENRVKDNLEKRlfRIFVAEEEEIVIKKNNKSEVKKvmFPGYIFVQMKMTDQAWYVVRNTPGVTGFIGSSgkPFPVSEDEMESILRRMGHGDQkvVDFQVGDNVKILTGPFANMIGRISAMNDQTQIATVMtlFGRETPNEISYGDLQKL
101 UniRef50_Q87A27 Transcription antiterminati... 129 4e-29 1 15.5% 1:161 1:184 MKRWYVVHAYSGFEKSVAQALRDRIsdVLVPAEEVVEMRSGQKRRSEHKFFPGYVLIQIeiDNECWHLVKETPKVMGFIGGtdRPLPISSDEADVILRRVQDgpRPKVLFEPGQMVRVIDGPFNDFDGLVEEVNYEkrLRVAVLIFGRPTPVDLDFGQVQK-
102 UniRef50_C8QDS8 Transcriptional acivator Rf... 129 4e-29 1 45.8% 1:155 1:156 MENWYVAQTKYAQEKRAQQQLLSQGVTCLFPVFSEVrqNGGIRRIAEQPLFPNYIFVRFDPEVVHTTAIKATRGVSSLISFGGLPSVVPDSVIIRLNQGWERAPLNTDAPVHGDRVVIRDGAFEGLEAVWYEPDGLKRAMLLLTLMNREVRVPVE-------
103 UniRef50_B8E0K4 Transcription antiterminati... 128 5e-29 1 23.3% 3:161 5:174 --KWFVVHTLAGHEHKVKAILERQvfEIVVPEEKVMTVKGGKKRIQVKKVFPGYLFIRMIEDEDVIRMIRNTTGVTGFVGTPGRPSTLNPQEEHWIRRFLEQKEIRPekVKKGDRVYIKSGPFMGYEGFVDEVYPEktVRVLLSIFGRETPTEIDHTQVEK-
104 UniRef50_Q0F316 Transcriptional activator R... 128 6e-29 1 29.1% 2:152 4:160 -KQWFAIRVKPRQESLAAANLERQGFEVYLPMINTRISHAGKVSWQPRPFFAGYLFVHLSIDEQRWTTIRSTVGVLAPVAFGTFYPPLSDQVIALLQARHDesSTPESPFRAGEKVRMLDGAMKGLEGVFIEMRGQDRALILLDWMKKSMRV----------
105 UniRef50_B8KUX9 Transcription termination f... 128 7e-29 1 35.3% 2:151 21:170 -RRWYVVASKPRSEGVAKSQLERQGFVTCAPRIKLRKRQRGKWQQVIEPLFPGYLFVALRLGVDDPAPIRSTLGCIGLVRMGREFVPVPEAVMQPLLSIGESPDASEAVFQPGQAVRFEAGPFEGLSGIFKMPKGQDRAEVLITLLGSSAR-----------
106 UniRef50_C0QWX1 Transcription antiterminati... 128 8e-29 1 18.0% 2:162 11:195 -YKWYIVHTQHGYENKVRERIEKriVDIYIPSETVTSTKNGKKVSKEEFFYPGYVLVKMVMNDATQSMVRRTPGVAGFIGSHAtpTPLSESDVARikSKTGINEIIGMEFDIGEKVQVIDGPFNGLNGIIENIndKGRVTVKIEIFGRSTPTELEFSKVKKL
107 UniRef50_B6G0A9 Transcription antiterminati... 128 8e-29 1 19.4% 3:162 8:180 --KWYVVHTYSGHENKVKATIERAVItvVVPTENVVEkpKGNEKIRQRKVYPSYVLIKMIITDESWYVVRNTKGVTGFVGPGSKPVPLSEEEVIAMGIELPAQEVvdVDFEPGDVVKIINGSFAGNVGTVEEVNAEKkvKLLTEIFGRKSPVTIGIQSIEKI
108 UniRef50_Q2JTQ7 Transcription antiterminati... 128 9e-29 1 20.8% 3:161 40:221 --RWYAVQVASGCENKVKSTlaDQIVEVVIPKRTGFKlrSGKRQEQEEKIFPGYVLVRMDLNDDTWMVVKTTPNVINFVGTEErpRPLSPSEVQRIFSSVEVEEVpkIDMAPGDRIEVLSGPFQGFYGEVVDVSPErkLKALISIFGRDTPVELEFGQVRK-
109 UniRef50_C7GYQ7 Transcription antiterminati... 126 2e-28 1 18.1% 3:162 32:198 --RWYVVHTYSGHEQKVKDNILklILKINIPTEEKVEIKNGQRKSRKVKQFIGYILIKMKVTNESWYVVRNTQGVTGFVGQGKKPVPLTAEEVRRLGI---EKVIVNLKIKPGDTIKVINGPFEGHNGEVIEVdeHETLRAKIFMFGRETPVDLEYEQIDKL
110 UniRef50_A6GM36 NusG antitermination factor... 126 2e-28 1 29.8% 1:161 13:178 MAQWYVMYTKPRQETVALENLQRQNYNVFFPQARVQKRKTGqtVQVVEPLFPRYMFIQLEVGVSDFSKLRSTKGCVDLVKFGGKPSVVPIELIELIQHQLDSDSVLdnELEVGGEVRVAEGPFEGMMGKIAARKSDQRVIVLLNVLGAERSVELAQSQLDK-
111 UniRef50_Q1Q029 Similar to transcription an... 126 2e-28 1 17.6% 4:162 8:168 ---WFAVHTRSRHEKQVDSFLREKNISSFLPLVKTISRRRDRKKFIDVPLFPGYLFVNITLDNL--YEIKSTRGVVRIIGNEDdpSPIPDAEINNLKTLINSNVAIDpyLQKGTKVRVVSGPLIGLEGLLVKRKTNYRVVVSIDILQKSTSAEISIADIESI
112 UniRef50_C7PUS0 NusG antitermination factor... 126 3e-28 1 21.9% 3:162 14:173 --KWYVAYTRANFERKVAKDIVDQQIEHYLPLRRETRKWSDRLKQIEVPLFPNYIFVKIKLQHKV--NILGIPGVLSLVSFSGQPVSVSEREIQHIRKIEERGqaLEYYYCVGDRVRITQGIFTGMEGILLRKSGQMRFVLKLPAISQAVSVEIEGDQLERI
113 UniRef50_Q01XJ6 NusG antitermination factor... 125 4e-28 1 20.1% 4:162 20:178 ---WFAVKVRSNFEKKSADILREKGYQEFAPSYPSRRYWSDRVKVIDQPLFPGYVFCRFHPN--HFLPVLQTAGVVQIVGFGGKLAPVDEVELASLRTLMNSSLpqREFLHVGRKVLIRRGPLAGVEGILEEIRKGYRIVVSISLLQRSVTAEIDANWVTTV
114 UniRef50_P36265 Transcription antiterminati... 125 4e-28 1 18.9% 3:161 22:203 --HWFAVQVASGCEKRVKLNLEQRilQVEIPKTPIVKIRkgARVQGEEKIFPGYVLIRMIMDDDAWQVVKNTPHVINFVGSEQkpMPLSHGEVERIFRHVDeePVVKIDMEIGDHIMVLSGPFKDFEGDVIEVSPErkLKALLSIFGRETPVELEFTQVEK-
115 UniRef50_B3T6R2 Putative transcription term... 125 4e-28 1 17.5% 3:162 97:270 --KWYILQAYSGYEGRVEQTIREKLreIFIPSEDIIRTKEGKKRKVNQKYFPGYVLIHMELTPELWHLLMNVNRVSGFIGGtkKPLPLDEKELEEIRSQVNEgkATEDEYSVGQKVTITEGSFGNFSGTIDEVneRRKLKVLVSIFGRPTPVEVEFENVKHV
116 UniRef50_B0SAG6 Transcription antiterminati... 125 4e-28 1 17.0% 2:160 7:181 -KKWYVLQTYSGHENKVKTnlEDQIFSVKIPSMEVAEMKNGKKKVTKKKLMPGYVLVEMNMTDDLRFKIQNLPSVSTFVGGKGkpEPLSLDEIKNLFSDVGNVESEEVsfKVGETLKIIDGPFANFTGLVDEIFPDkrLRVRVEIFGRSTPVELDYLQVK--
117 UniRef50_C0W699 Transcription antiterminati... 125 5e-28 1 23.8% 3:162 63:263 --EWYVLHTYSGYERRVAAdlEDYVFDAVVPMETVIEVKsgKKKEVSRVRIPGYVFVRMDLDdrVWRTIKDTPAVTGFVGDRYNPVPLTFDEAVSQLGpvEGGQVYEVAFEVGESVIVTDGPFESLPATISEIHPeqKLQVLISLFGRDTPAELSFTQVAKI
118 UniRef50_A6GCJ0 Transcription antiterminati... 124 9e-28 1 19.4% 7:161 1:172 ------MNTFSGYENTVKKSLEDRIkdILVPSEQVIEQRGKRQVKQTRKFFPGYIFVRMRLTKPAWHLVKNTPKVSGFLSSGKTPKPVSQREMDRMLGKTEPKQVTEedYSVGDQVRVKSGAFANFSGEVEEVNTEKriKLSVSIFGRPTRVEVDFSEVEP-
119 UniRef50_B1VAN1 Transcription antiterminati... 124 1e-27 1 18.8% 3:162 30:203 --RWYIAQTYLGYENTVKQDLLRriSNVLSPRETYYETrdGKKTSKERNLYPGYVFIEMIITDHSWFVVKNTPRITGFLGSSgkPIPLSEKEINPVLFKMGIMSKPNYDHLIGKKVEIISGSLANQQAKVSIIddREKIIVEVDLFGRTVPVEISFSDFKEI
120 UniRef50_Q5QWY1 Transcription antiterminato... 123 2e-27 1 35.0% 4:160 9:163 ---WYIVRTKPKQEERAILNLENQGFGVFAPELTVKKVRRGVRTSVVERMFPGYVFVKPDDIIEQFYKLRSTYGVAGVLRFGDNIPKVPQRWIDQMRGV--DQLTDEQAPQIGDTVEIQQGPFRGFLAKIVKLDGESRCFVMLEWMQKEVKANFSYKELQ--
121 UniRef50_UPI0000E0F5F6 transcriptional activator R... 122 3e-27 1 38.8% 2:161 15:174 -KVWYLLYCKAKEEGRAVMHLANQGIDAFYPKANITKVLRGKRQTVEEALFPNYVFAQLDHDVHNFTSVRSTRGVIGFVKQGKDYQKVSQALIDVFVQCDTVDKLDSALPTKGDNVMLQHPQYQNIPAIYQEPKGENRAILLIHLLNKPVELVVDNSQFTK-
122 UniRef50_C4V5M2 Transcription antiterminati... 122 4e-27 1 19.6% 2:159 16:182 -RAWYVIHTYSGYENKVKANLErmIFDVVVPVENEIEVKDGKEKVVPRKVFPGYVLVDMIVDEHSWYVVRNTTGVTGFVGSEKHPIPLTAEEAERILssVGAEPKRRTKVNVGDTVRITSGAFEDYAGKITSIdsSMGVKVDVD--GKSLDVEIDQVEL---
123 UniRef50_C6Y0K9 NGN domain protein n=1 Tax=... 122 5e-27 1 21.7% 2:162 8:167 -KNWYVVVTYPNLERKALLNLLKNNFIAFLPLQKVQRKWSDRKKTIEIPLFPNYLFINI--NEKDRFEALDIYGVKRYVTFGGRPAFISETDILNIKRIVESVDLyeHSLVKGDAVKIIGGPFKDMIGILFKKSGQARFGIRVESMNQTLSIEICHTLIRKV
124 UniRef50_Q7UMY8 Transcription antiterminati... 120 2e-26 1 18.6% 2:162 48:225 -MDWYILKVAFNREDSIAEALRKKVrdIVVPSEDvtFTRDGKRRVSKRKLLPGYIMVYMSINDDTWFLVREVGGISDFTGSAGKPQPMEPEDVERFINRPAVDDEDEtpFKVGDRVRVKEGNFENQEGEVDVVDenGRVTVIINIFGRSVPMELDHWQVEPL
125 UniRef50_C6QI43 NusG antitermination factor... 120 2e-26 1 23.1% 4:159 15:172 ---WVVVNAQAHREFVAASNLKKQGYEIYAPVIRKTTRHARISRESLTPLFPGYLFARWTAPDMRWRPILSTVGIRSIVRNGNEPSRLDGAIVDALKAREKDgvRAESQREIGQIVRFARGPFDGIAAEIVELCDKDRLVVLMTLLNRPTKVTVLEDQL---
126 UniRef50_A6FES1 Putative transcriptional ac... 119 3e-26 1 40.3% 2:160 6:167 -KDWYLLYCKGKEEPRALINLKNQGIESFYPTMTVEKKLRNKLICQEIAIFPNYLFVAIDKNTANFNSIRSTRGVIDFVKCGANYTKVPAALVTELrrCRDKSANEVTVFSEGETVIIQDGAFKGIEAIYQCKDGLERSMLLINLINHSTTMSVANGEIK--
127 UniRef50_Q01TC5 NusG antitermination factor... 119 3e-26 1 23.8% 3:162 18:177 --QWFALSVTPKLTQLVLMALEHKGYECFTPLQSSTRKRRDQVADMQVPAFPGYVFARIDV--RFRLPVLVTPGVRGIVGYGRQPAPVDDGEIFALRRVMQSQLPAkpYLRTGDRVQLVEGPLSGLTGLLIQQKGANRVLVQVTLINQALAVDVESAWVRSL
128 UniRef50_Q2S1Q0 Transcription antiterminati... 119 4e-26 1 15.3% 4:160 10:182 ---WYVLRTFSNHEKKVRRYLedQVEEILIPTETVFEMKGGEKKTKEKTFFPGYILLNCTLTSDLRDLAEDLPSVIGFlgTGDEPTQLREEEIKRILGKMDrgEQPEMPFKVGDPVKVVDGPFDSFNGIVEDVYPDqkVKVMVSIFGRKTPVELDYLQVE--
129 UniRef50_C8VZE8 Transcription antiterminati... 119 4e-26 1 13.8% 2:161 1:163 -MHWYVIHCLTGHEEDVRSRVKEKDirAVVPRRLMVERRQGGWQYVERVVFPGYVFVQAHMTPAAYYAMRNLPGVIRVLG-TSRPVPLMGNEVTLFLKLCRDGDplSEVFVKGGSVKVISGPLMGLEGHIVKLDARrrAKVNISLMGEPRIVELAVSVIKK-
130 UniRef50_C7PUF8 Transcription antiterminati... 118 6e-26 1 16.9% 3:162 20:195 --KWYVLRVVSGKEKKVKEYLdnVITQIFLPVEKVYKVQAGKKVMREKNFYPGYVMIEAimTDEVIQSIRNVSGVIHFLG-KDKPIALRKAEVNKMLGKVDegLTMSEPFIVGETIKIIDGPFNDFNGIIEeiEDKKKLKVTVKIFGRATPVELNFMQVEKI
131 UniRef50_C9RQP0 Transcription antiterminati... 118 6e-26 1 21.4% 2:160 3:175 -MQWYAVHTFTGQENNIKKRLEQMIEriIVPTREVVSNVRGKRRISVQNLFPAYIIIEMELDELTQHLVSTINGVTHFGGMTRapIPLRQSEVDRLLGVDPeeGEIQIPYTIGENVCIKEGPFKGFVGVVDEI-MEAKIKVMVSVFGRSTPVELAFNQVE--
132 UniRef50_Q1Q133 Transcription antiterminati... 118 7e-26 1 19.3% 2:162 3:182 -KEWFVLRVQSNREDKVRDNLVERIrnVLVPSEKISEVKGGKKRVSDRKIYPGYIMVEIEVDeeVWFTIRETSGTGEFIGGQSKPVPMTKYEVEKLLsqKEERPRAKIEFNEGEKVRIKEGPFENYDGIVEEVLpsGRVKVMLTVFGRATPVELEYWQVESI
133 UniRef50_Q04WD1 Transcription antiterminato... 117 1e-25 1 22.2% 3:160 9:170 --EWYALYTNPRAEKKLKRLLQERKIECFLPLISKKKKWSDRWKVVEEPMYPSYIFVKISFFQD-RVKILQLPGAHHFVFYSGKPYVIPDEDLNLIRIFLEtqVEIQERLLPGKKILIQEGPFAGFKAEIIQRKNEKQIIVKFPGMNLMTSVTLDIKTLK--
134 UniRef50_A4EGG1 Transcriptional antitermina... 117 1e-25 1 27.8% 4:161 10:170 ---WFVLQLKPNGLSLARTHLARQGFLTLMPLREVSQHARYGLRTVRQPLFPGYLFFSVTARQINWPAAANTRGVTRivGTDGQPARLPADIAAGLLAITTEDGmdVADLQTGDQVGVVNGPFAGWMAKVVSADTPDRIQLLVDVMGRETAVNIAGRDLEK-
135 UniRef50_C7NC81 Transcription antiterminati... 117 1e-25 1 24.2% 2:162 16:205 -KKWYIIHTYSGYEKKVAADLEKRifRILVPEEEVLEEKRGKQVKVSRKLFPSYVMIEmrVDSDAWYVIRNTNGVTGFVGVGSDPIPLSDEEASNLLAKIGIDVEGEtdFKVGEVVEVKGGSFDGQQGEIAEIdeHGKVKVMLEVLGRLTPVEVEHTEIAKI
136 UniRef50_Q982S4 Transcription antiterminati... 117 1e-25 1 21.2% 3:162 13:181 --RWYVLRVEDRADIAVDKLLGEANVERVMLHTECEAKRRGRRKhvRVPSFPGYIFVKVVSCAATWAGLRTVSGVLGPIGGCDGPSPVSEQEILKFQARIENDPEatNALKAGDKVSIDSGPFAGFEAVVLMLGDKHKVHVEVDIFGRKTPIGFALAEVTKL
137 UniRef50_A1VS68 NusG antitermination factor... 117 2e-25 1 21.2% 4:159 23:181 ---WFLAHTRPRLETVALQNLQQQGFDVYLPLYKRLKKIDAGMQAVFEPMFSRYVFFRTTSLAQSIAPVRSTRGVAQIVSFGSEFATIRPDMLDAIRQLEqaDVAELSTLRPGHLVRFCNSALSGLEGVVKSVS-SCRVAVLLEIMGRQQLVRVDHHQL---
138 UniRef50_Q3AU98 Transcription antiterminati... 116 2e-25 1 20.6% 3:162 9:170 --NWYAVYVRSRYEKKVYQALLEREVNSFLPLYETIRQWSDRKKKVSEPLFRGYVFVNIAMQQESI-KVLDTEGVVKFIGIGRKPSVIAEREIEWLKKLVREPerTVASLPAGQKVRVIAGPFKDMEGVVVKEGRESQIVIYFDSIMQGVEVSIYPDLLQPI
139 UniRef50_B0VGC6 Transcription antiterminati... 116 2e-25 1 18.9% 2:160 1:173 -MKWYVIHTYSGHENKVKTalEKQVGRLLVPVRKTFVIREGKKIERDKKLFTSYVIMEADMTPELKTYILQIAGVTSFLgeHKEPIPLSQEEVDRLLGITdnRDIKVYSYMPGDMVKVISGPFTDFEGIVQKTTENgkLIIEVTVFGRRTPVELNASQVE--
140 UniRef50_B3ETZ5 Transcription antiterminati... 116 2e-25 1 19.4% 3:162 6:185 --KWYVLKVVSGQEKFVkrKLQDYVAQILIPSEKIYEMRAGKRQTRERNFFPGYLILHADLSdrVLHTIKDIPNALGFLgsSSQPIPLREKEINKILGRVDEIAEdeKPFIVGETVKIVDGPFSGFTGNIQEveERKKLNVIVKIFERNTPIELTYTQVEKI
141 UniRef50_A5TS63 Transcription antiterminati... 116 2e-25 1 21.0% 1:162 6:193 VRKWFMIHTYSGYEKKVKTDLEQkvTNILVPEEELTEIVRGKPKKIYRKLFPAYVMLEMEATREewYEVRNTNGVTGFVGVGSDPIPMEEEEVKNIFNIIgpKETIKIDFAEGDYVKILKGSFKDQEGQVAEIdeHGRVKVMVDIFGRMTPVEIEVDGVLKV
142 UniRef50_C6XVK8 NGN domain protein n=1 Tax=... 116 2e-25 1 21.6% 1:162 10:172 IKKWYPVYTQSRAEKKAYQALLSKGIEAYLPLQRQLRQWSDRKKWVEEPLIKSYLFVHIARQQQT--EVLMTTGISRFIYFSGKIAAMPDRQIEELKLLLASpeITEERLLPGEKIEIKAGPLKGIRGEIIEYRSQKQLLLRLGDISHSIVVNVSASLIERM
143 UniRef50_A3V684 Transcriptional activator R... 116 2e-25 1 27.2% 4:161 10:168 ---WHIAQLRPNGLLMALRNLERQSVAHFAPTELRTERRGAKFVTRDVPAFPGYVFVQPSAASGGVRAVNSTRGITKLVTLGQGPAIVPAGLIAALRIRFAPPDITppQFDQGDWVRILDGPFAEFVAQVEATPAAERVYLLIDLMGRATRVAVDARSLKR-
144 UniRef50_C0QI35 Transcriptional antitermina... 116 3e-25 1 20.8% 2:160 5:167 -KSWYTLLTKSRFENVVFNDIQKKSIEVFLPKIKKRSQRKDRKLMIDVPLFPGYLFVNITLDPVTHLSVVKTTGAVRLLGYSSGPVPVPSAHIESLKIVTGTGLDVvnTLQKGERVLVVRGPFSGVKGEFLRHKGKDRVIIKIETLGQFAGVEIDREDLE--
145 UniRef50_B4S8Z4 NusG antitermination factor... 115 4e-25 1 19.5% 4:162 9:169 ---WYAVYVRSRFEKKVHLLLQEKGIVSFLPLVDTWRQWSDRKKKVSMPLFRGYVFVRIHYRQDHPF-VLDTDGVVKFIGIGRAASVIRDRDIEWIKILTGEPDVRKEvlPPGKQVKVIAGPFVGLEGVVRKDGRESKLVVYFESIMQGIEVTINAEYLSPL
146 UniRef50_Q1ITB0 Transcription antiterminati... 115 4e-25 1 20.0% 3:162 13:172 --HWFAVQTRHRHEKRVAERLRQSEIETFLPIHRAVHRwnGINAEVNLPLFPGYLFTRLRGSQRI--PLLREPGVIAIAASSNSPTPIGDNEIAQLRLVAESVKAEPHPfaIGQQVKVVAGPLFGMEGILIRKKSEYRVVVSVKIIMRSVAVDVSELEIEPV
147 UniRef50_Q1D5E3 NusG-like protein n=2 Tax=M... 115 5e-25 1 19.4% 3:162 10:166 --DWVALLVRVNHEKVAAAQLGKHGYEFFLPTYTPPKSSGVKAKL---PLFPGYLFCR--YQPLNPYRIVRAPGVIRLLGGDAGPEAVPAQELEAIRRVADSGVSSNPclRVGQRVRIIEGPLTGLEGSLVTSKSQLRFIVSVGLLQRSVSVEVSAEQLEPI
148 UniRef50_O83264 Transcription antiterminati... 115 5e-25 1 20.5% 2:162 3:185 -KEWYILHTFSGREARVERAVrnVIFDIKIPEELLTEVKDGKKRVVRRKFFPGYLLVEMDLPEVDWreVRRIPGVSGFLGSSgkPQAVSADEARRILQKAGEipRIAQTFLVGQQVRIVEGPFATFSGEVEEvsERNKVRVAVTIFGRATPVELELVQVEAL
149 UniRef50_C6PET8 Transcription antiterminati... 115 6e-25 1 18.6% 2:162 5:175 -EKWYVIYTRTGDELKVKRLIekKPIRVLIPKRAIIERKGKKRVEKIKFLFPGYVFIKTNMCFEIYYEISKLPHFLKFLKDEMEPAEVRDDEIRIILSLVGDSDifSTGIKIGGKVKIIDGPLKGFEGLIEKIDKRkrVKVRLNVSGNANLVDLGIHIVEKI
150 UniRef50_C5EKF0 Predicted protein n=1 Tax=C... 115 7e-25 1 15.4% 1:162 1:170 MERWYAVQVRTGREEAVLQLSKKMikECFIPYYERMKRYQGEWHKEQYILFPGYIFLVTEQVDELFWELKKVPGLTKILGDGMEFVPIKEEEKVILQKMGGSDHIAEMsyVIGDIVTVISGPMKEMKGKIKFIDRHKRLAveIEMFGRKTEVRLGLEIVMKL
151 UniRef50_Q5GRY4 Transcription antiterminati... 115 7e-25 1 17.4% 2:162 99:276 -YKWYILRVASNYEEKVCQHVLENSmeVFIPYEELSEVerSKKAAMRRKCFPGYVFLYVDLCDEVLNFVNNIPkvYGFLKNGSVPKVISDDEIYSMCNAlqETKKLSHGYEKGEKVKINDGLFQNFTGKVDMINDEKKIiiEVSILGKPTIIELDLAQVEKI
152 UniRef50_C8WL22 NusG antitermination factor... 115 7e-25 1 16.1% 1:161 1:170 MALWYVVQTVGGQEKHVLDLieELIQESFIPQYEVKKRIQGVWKMRSEVLLPGYIFVITDQPGKLREALRSVPKFTRLLGNNDVFTPLDDQEVAFINAFTKPDHRVVEfvMEGDEIVILNGPLMNQTGLIKKLDRHKRLalEIEILGRVKTVKVGLEIVRK-
153 UniRef50_C7PTI0 NusG antitermination factor... 114 1e-24 1 20.6% 3:162 14:173 --KWYVLYTYPLFEKKIGRQLALIDIIHYLPVKTEVRKWSDRLKRMEVPLFPNYIFVKTNLLNKT--PILGIPGVVRFVSVEGRAIAISEDDINKIRQIEQsdVEIESVYNTGDKIRILNGVFSGLEGELYKRSNRLRVLIKLPVIAQAVSVEISNCDIEKI
154 UniRef50_C7PGB9 NusG antitermination factor... 114 1e-24 1 21.2% 4:159 8:163 ---WYAVYTKPRWEKKVADALVRKQIETYCPINRVTHQWSDRKKIVEEPLFKSYVFVRIP--EDKKTLVRETSGIVNFVYWLGKPASIPDHEVELIKRFlqDVQVERFPIQEDDLIRITAGPLMHQHGRVVEA-GKNTVKAVLYSMGFSLIATVKTSDL---
155 UniRef50_Q8R8A2 Transcription antiterminati... 114 1e-24 1 23.3% 4:162 16:178 ---WYVVFTYHNAEKRVEEHINSliIKAEVPVQKRTVSRRGKIKEIEEKIFPGYVFVKAVMTPEVMAAIRRINGVAHFVGGGNEPVPITPEEVKRARIQDDLSEE----FKAGDTVMITDGPFENFIGKIIKIEGRK-INIALSLFDREMGIDFSPEQIMKI
156 UniRef50_Q2CAE9 Transcriptional antitermina... 114 1e-24 1 28.8% 6:161 1:161 -----MAQIKPNGLRLATQNLARQGLAVFCPLQQASRRIRGQIRSVTKPVFPGYLFVSLAPAGGEMRAASYTRGVARLVtdESGPKAVPDALIEELQARCTPepPEADQLDVGDRVWVTDGPLAGQVSRIIALAPEARIWLLLDLMGRQTRVAVKREAVRR-
157 UniRef50_B9KHV6 Transcription antiterminati... 113 2e-24 1 16.2% 3:162 11:186 --EWYIVQVSSGSEEKVAQMILERSqeVFIPYEEVTKVKYNKKVAMRRKLSPGYVFLYMRLSDDAINFVRRVPKVSNFLLDdgLPKVIPASEMETMRSSmsEAASEVCSFEVGDEVVINDGLFQDFNGRVEYVNEDKKVavSVMIFGRLTKIEFKLSSIQKV
158 UniRef50_A3XR75 NusG antitermination factor... 113 3e-24 1 23.4% 2:155 1:154 -MNWYVLYVKPQSEKKVASALEKLGVKVFCPTLEEVRVWSDRKKKIQVPLFKSYVFVCLPNTE--RQQVFAVPGVVRYLFWLGKPAVVRDEEIAAIQDWLSDedVQVRTYTPGTEVKIAAGHFKGQKGIVQEV-GRKRLKMVIKSLGVIVEARLK-------
159 UniRef50_O51355 Transcription antiterminati... 113 3e-24 1 16.1% 2:162 3:184 -RAWYVVQTYSQYEKKIEQDIRLLilDVKAPIEKVEEIRNGKKRIRERKIWPGYILIELDLPEVGwaNIIKVQGVINFVGvgQRPIPINDEEVKSVFMLTGEIKANkyDFEEGERVRIKGGPFDSFEGLISSIdeRKKLKVAVQIFGRSTPVEVDFQHIEKI
160 UniRef50_B0A697 Transcription antiterminati... 113 3e-24 1 15.0% 3:162 8:179 --KWYVVHTYSGHENKVKATIEnyIKQVIVPTEDVIEtkTGKEKVRQRKIYPSYVLIQMIITDESWYIVRNTKGVTGFVGPGSKPVPLSEEEVKSMGIDLDKIGEKRTEIEVGEVVNVRDGVFKGQSGVVKELdkNEKVKISvnGTSGELSLELDLKSIETI
161 UniRef50_B5YJ95 Transcription termination f... 112 5e-24 1 17.7% 3:160 7:167 --NWYCIYVKSRHEFKVFDRLTKAGIEAFLPAVERLRRWKDRKKLIKFPLFPGYLFVCIEKSYELMLKVLKTPGVVTFIksGEPEPIPEEEIVPLRKAIENGREIDppYLKEGQRVKIKSGPLAGATGILKKKEKQHFFIISIHILQRAVSVKIDASEVE--
162 UniRef50_UPI000197AEF0 hypothetical protein BACCOP... 112 5e-24 1 15.1% 2:160 4:166 -ENWYAMYVRMHHEKKVAEKLGQMGVEHYLPVQEVVRQWSDRRKKLQVVVIPMMIFIRAS-EQVRLSVMRNIPSVSGClrCTHRPAVIRDEEMQRFRFMLDYSEEAVHFInpGQKIRVIKGPLAGLDGELTEIDGKSQVMVRIEQLGYA-SVEMPVGYVE--
163 UniRef50_Q1NMQ2 NGN n=3 Tax=delta proteobac... 112 5e-24 1 24.4% 4:159 10:171 ---WYAIRTKPHKEEMARQHYLNQQYTVYLPLMRVVRSHARRRQVVFRPVFPGYLFLRLNPETCDWAAIHATRGSIGPLRFGEHYVPVPDWVIEGLQAREDEEGvqKEKLVPGCEVEVTMADGSAGKGFFCSFRGKENVEILMDILKRQVRTTVPLDRV---
164 UniRef50_C8WIE4 Transcription antiterminati... 111 7e-24 1 19.0% 4:161 2:168 ---WYVAQVQAGRESSTLEMCRRLveDCFMPEYEVMWKIRGEWRLVKRLLFPGYLFFVTDDPEALNRELSRVPMPIRLLGNEesFFPLTGKERDWFLSFMDGNhrMSEGYISGDKITVTRGPLMGFEGDIRKIDRHkrAYIDVSLFGRTVPASVGLEIVRK-
165 UniRef50_A6EBM5 Putative uncharacterized pr... 110 1e-23 1 19.5% 1:159 8:167 IKKWYPVCTQSRAEKKAYSELTRKNITSYLPLQRQMKQWSDRKKWVEEPLIRSYLFVHISRQQQ--AEVLMTSGIARFIYFSGHIASMPEQQIEQLKLLTASpeITENNLLEGEKITIKAGPLQGMSGEVVAYRSQKKLLVRMTELNHAILVHIPASLI---
166 UniRef50_Q1IKV1 Transcription antiterminati... 110 1e-23 1 20.4% 3:159 26:182 --SWSALFTYPRHEKKVAEQLLCRGVESFLPLYAEKRTWKNRQTVTLtpLFPGYVFARFARRDRVR--VMSLPGVVSIVERAGAVSSISDHYIEKLRAGIRLGRVRPFREAigDRVQITSGPLSGLEGVLMHFRSEFRVVVSIGMIGQSVSIEVLRDEI---
167 UniRef50_C7PS65 NusG antitermination factor... 110 1e-23 1 20.8% 4:162 8:169 ---WYALYTMPRHEKKLHTRLSELNVTSFLPMTRMLRTWHDRKKYVEMPLFPSYIFVYLN-NIEHYYNVLNTNGALYYVKTGNELSRISEQIIHYIRIVSEQseLSADYFPPGKELLISSGPLAGFSCEVVSYKNSEKILVRVSLLQRSLLCSYTADSleKL
168 UniRef50_Q6AIA2 Related to transcriptional ... 110 2e-23 1 24.1% 3:160 28:191 --HWYAIRTKNKKEEVAKFNYQRQGYTVYLPLLRKTVHHARSTTEKLVAFFPGYLFLNLAPAEQNWTAIASTRGSLGALCFGDSYIEIPGWVISDLKAREDKgdLIKENLTPGSVVTVNIPGLESVEAVVYSIRGSENVDVLLNILSRQVKTTVSLDRIK--
169 UniRef50_A9ECY4 Putative uncharacterized pr... 110 3e-23 1 20.0% 2:161 27:187 -RNWFVLYTAPRAEKKAKLELEYRGYEVFLPMTKSLRIWKNrkKLIDSVLFPSYIFVKTD--ERYLAEICRINKIATYIHCGGKPCKVSPECIEAIKCMLSMDQEISvdFIEGESVRIVEGPLAGYNGVLVQQKSKTKFGIHLKEINQVASIEICTSALEK-
170 UniRef50_A6L3Q7 Putative transcriptional re... 110 3e-23 1 14.8% 1:162 1:165 MKKWLVAYVRLHHEKKTAERLTAMNIENFLPVQEEIRQWTYRKKKIKRVVIPMMIFVHVDAAERSQVLTLSAISRYMVLHGEHTPAVIPDEQMERFKFMLDYSDEAVEmlAPGELIRVVKGPLKGLEGELVEVDGKAKVVVRLDLLGCA-GVDMPVGFVEKM
171 UniRef50_Q5LEP1 Putative LPS-related regula... 109 3e-23 1 18.2% 4:157 15:169 ---WYAVYTAPRAEKKVKEQLDKIGVENYLPLQPVVRLWNNRKKKIFIPVVPGCLFVHISSEEIAH--VAGIHGVAFLLKEKGQYVSIPEVQMETFKTmcELVEFAPNEFVPGTVVRVISGQLQGLEAELVECQGNNKLLLRVEGLGCAL-VTVSTD-----
172 UniRef50_C7PT75 NusG antitermination factor... 109 3e-23 1 20.3% 4:161 8:167 ---WYLLYTRPRQEARVAKEMADKNIQIYLPYTTVTRRWTDRIKVLEVPLFPSYVFVHLT-NMHEFYYGSNLESACSYVRFGNEVARVSDAAVDAVRTIAKAgeVSSERFTPGQQMMIKEGPLCGLNCEVIQYKGKDKILVRVHMLQRSIMADMPASVLIP-
173 UniRef50_B9XAW5 NusG antitermination factor... 108 5e-23 1 26.9% 4:159 34:192 ---WYCVRSKPKHEHIAAANLSkqVVETFNPSLRSRKATRRGPVWMTESLFPNYIFARFPF-EQMFDEVKYTRGVSSLVHFGTGYPEVPADVIEELRrpANELKLSSEVPTAGDQVTITSRALFGLQGVVLrmPAQRRVQVLLDMLGQTSAVELNLNSV---
174 UniRef50_D2QI92 NusG antitermination factor... 108 6e-23 1 23.1% 2:161 1:160 -MPWYVLCTKPRKEKFLAKLLAEKQIEVYCPLIRRKRRWSDRIKTVEEPLFPCYCFVNVKESERADVFV--TPGIVRYLYWLGKPAIVKDKEIDLilNQFDHDLIHLESFNPKDKVVINSGSFMGQGGTVVNQQG-IKVLIHLDSLQLCIRVDTSKTLIAK-
175 UniRef50_C8WIA3 NusG antitermination factor... 108 1e-22 1 16.5% 4:161 2:168 ---WYVVQTVAGREFAVCRLIESLvqECFVPRYEVQKQFRGQWRTCTATLFPGYLIVVTDRVDELESQLRRVPAFAWVLSNDGGFVPLERDEVAWIDAFTEKGHRTveGVIEGDRIIVLKGPLVGREGWIRKINRRKRTalEIDMFGRTIQTKIGLGIVRK-
176 UniRef50_A5FN19 Transcription antiterminati... 107 1e-22 1 22.4% 2:153 1:152 -MNWYVVYTKPKWEKKVAEKLTQIGIECYCPLITQVKQWSDRKKKVEMPLFNSYVFIQI--EDADRNSVFEVAGIVRYLFWLGKPAVVRDEEINVIKNSLKAsdISVSQIQVGDKIKLETGAFSNQNAIVQEVSKTHYILV-LESLGCVLKIK---------
177 UniRef50_B5Y935 Transcription antiterminati... 107 1e-22 1 19.9% 1:161 1:180 MKKWYIVTTVHGKESAVAEAIKLriSDVLVPKEWRLEYRGKKPrrVQRVIYPGYVFVEVeiDPETWSLIRYTPGVRGFIStdHTPIPVQDNEMEKVLQKSREQEAVKVDLQTGDEVEVRDGALKGLTGVVVDVDHEkkVFVKISMFGREVISDLDAVQVRK-
178 UniRef50_C8PLY0 Transcription antiterminati... 107 1e-22 1 16.2% 2:161 1:170 -MDYYAVQVKTGKEPELLKKieNHEIQAYFPRRVLYIKKKGIRQKVDAPVFPGYIFLEIDDLSLPLcqLRKTPNFYHFLPNNQNPLPLVDNDLSLLHHFLSFGepSKVYFDANSRICVIDGALKGLEGKIIKVDRRkrAKVLLDMYTDSFPIDLAFDVIEP-
179 UniRef50_C3RLT4 NusG antitermination factor... 107 2e-22 1 16.9% 2:161 3:171 -ENWYVIQVRTGKEEKIKNTCEKLIseCFIPKCIRLKKYQGTWKEVDEVLFKGYVFMISDHIDELFNKLKLIPDLTKVLGNDGEFipILKEEAIFLLKFGKEKHIvsQGYIEGDKINIISGPLVGYEGMIKKIDRHKRVaiEVKLFDQITMVQVGLEIIGK-
180 UniRef50_D2LJZ0 NusG antitermination factor... 106 2e-22 1 28.0% 3:159 8:166 --KWVVLTTHPHRENFAVENLARQDFTAYCPMTVKHVRHARRAYDAPRPLFPGYVFVEHQSAFQYLRPILGTYGVRSILRIGDSPAVLPVGFIESLKAREMDGvkPEAPLKAGQTVTISGGPFDGLVGQILEFRERDRVLLLLDLLNQQTRVQVEAKML---
181 UniRef50_A3I2H8 NusG antitermination factor... 106 2e-22 1 16.9% 3:162 5:165 --KWFVMYTASRSEKKVAKRLRENGKEVYLPIIEEIRQWSDRKKKVEKPLFNGYVFVKTTRNQLWECL--QVPGAVKFVHFSGQHATVRDEELETIERIISTGVAVESdiEAGEKVEVIGGALQHMTGEVIEKGNKDYFLIRIPSIYQNMLVSIPRKFLQSL
182 UniRef50_UPI0001692BF2 putative transcription anti... 106 2e-22 1 17.1% 2:159 1:173 -MLWYVLFVTTGKEDVVGKYISnlSLQCFIPKKVVPECHKGVRRDVIRVLFPGYIFIRTTMSSNLYYLLKEIPNLHYLVNSGDrySAIPEEEMEWIRDLTGNRDTIEYSeiINKKVKVISGPLKGKEAMIKKVDKRkrAKIEVTLLNKTNLVDVGINIL---
183 UniRef50_UPI0001B49F58 putative LPS-related regula... 106 2e-22 1 18.1% 4:147 15:160 ---WYAVYTAPRAEKKVKEQLDKIGIDNYLPLQPVIRMWNNRKKKIFIPVVPGCLFVYISSEEI--AQITSIHGVAFLLKEKGQYVSIPEVQMETFRTMIERSHELVEffVPGSTVQVIRGQLQGLVAELVECQGNNKLLLRIEGLG---------------
184 UniRef50_A3J1W0 Putative transcriptional re... 106 2e-22 1 25.7% 2:153 1:153 -MNWYALYTKPRNEQKVAQKLQALGIIAYCPLVLSSKQWSDRKKKVLVPLLPSYVFVQI--EEQNRKDVFQVGGVVQYVFWLGKPAIIKPNEIEALKQQLDSSIPVVHfwRSNETIQITEGVFKGQDAIVDKISTNK-VRLLLKSLNMYITIE---------
185 UniRef50_A9DI26 NusG antitermination factor... 106 3e-22 1 20.3% 4:161 7:168 ---WHVLYVKSRWEKKVHNSLENISIKSFLPKTKTVQQWSDRKKTILTPLFPSYVFVYIE-SPLDFHKALSVDGACCYIRFGKEYARVTEKEINQIKLLVDSKEinPTFPKIGEMKKIEQGPLSGLDCEIIEAENYNKIIVRISSLRQNILATIPLNSFKK-
186 UniRef50_B3DWJ1 Transcriptional activator R... 106 4e-22 1 27.6% 4:159 11:168 ---WYCLSIQPKKEKLAVENLKKENIEVFFPQFQYQKIRSRKTSLVLEPLFPGYLFAKFNLYSKLTF-VRSTKGVRKVVHFGSSYPVIPDSFIEELRIQFGEekTIRERIDVGSTINIAEGPFQGYSCIVLgiPAKERVRVLLEWLGRAVQIEVNLKEI---
187 UniRef50_C4XFX3 Putative uncharacterized pr... 105 5e-22 1 16.5% 3:160 10:200 --QWYMISTVSGKEDKVVEALKNRIidCftPKELEKQKNGEEYKVKYVNMYSGYIFINMDMTDRAWFIVRNTQYVTGLIGSSgkPTPVSQHQIDkiKLQEDFDkvTHTKFQIGEIVEIIDGPFKGEQGRVLECSenKKVTVEIEYLGKKTPADFEYKEIK--
188 UniRef50_A7AFP3 Putative uncharacterized pr... 105 5e-22 1 20.3% 3:155 24:171 --SWYVLYTAPRAEKQVRDRINALGVECWLPLHRAPRVWSDRVKIVELPLFNSYLFVRCTDPEL--RNLTRVYGVARIVYYNGKPAVVRQKEIDAIQDFLD--QASEHALCPGEEVEILCGAMKHVSGKVKKIKKNH-LVLYLEQLGATVCVKLD-------
189 UniRef50_B4D2H1 Transcription antiterminati... 105 5e-22 1 25.2% 3:161 19:180 --KWYCLRAQPKHEHIAAARLRqeEIQVFCPRVRIQRSTRRGLVWFTEALFPNYLFARFEWVQ-SHALVRSCQGVSGIVRFGDHVPEVPAGTLDDLRAYMEDAELKTVSFneGDDVEIVEGPFRGQNGVVKQLLprERVKVLLEVLGGATEVDLCLTSVFK-
190 UniRef50_Q1QKQ8 Transcription antiterminati... 105 5e-22 1 20.4% 4:160 7:192 ---WYVLQTRPAHEDKAARGLVARGFDPYAPVVYRrrDDKGRkrEIARPMFPGYIFVQFDAGDEKFAEVRIVPGITGYLKDegEPQAVPDVAMDLIAVSETEekRGPPEFKAGDDVRVVRGEWKDWIMKVSKADDLGRVVLLFHIFGRETKIHADQADLE--
191 UniRef50_Q2ST07 Transcription antiterminati... 105 6e-22 1 16.2% 3:162 19:211 --QWFVISCQTGHEEKVLGDLQQKIkeVFSIKISKANQVSKSGKASIKNKFPGYIFINMIMSEKAWFLIRNTPGVTGFIGSSgkPSPLTIEETLNMLVPNIEEIQQAhdFKIGDIVKVKSGIHENEEGTVKDMDYSKGVavAIEMFGRWTTLEVSFKNVEPI
192 UniRef50_B9YBP8 Putative uncharacterized pr... 105 7e-22 1 23.0% 2:162 1:170 -MNWYVLFVRGGMEEKIRDFFLSQGLNAFIPKMKVVFRKQGISELVEKIMFPGYLFIESemDEQIKELRMQKTGIVKLLKFDKEGTplRSEEKDYLERLLGKNKVLEHslIQGNQVIITEGPLQGFESQIVKIDRHkrAVLELELCGQPRRVSVSLEIVQKI
193 UniRef50_Q3SSD1 Transcription antiterminati... 105 7e-22 1 21.2% 2:161 33:210 -KYWFILRTHPGCERKVMREFERRNISAYCPLirVVRRVHgiKRLVQVPLFPQLVFV-----PDFERVPADIGGVSGWLRFGGWRARIPSedIHALVAIANTPQSKRarFEIGALVRIVDGPFRDFSGRIERLDSKGRLKVAIEIFGRLSPTEMSEAQIEP-
194 UniRef50_C6LL07 Putative transcription anti... 104 9e-22 1 17.7% 4:161 17:182 ---WYVMQVQTGMEERICAQCRRKISecFIPRYEVKKHIQGEWKTQKQILFPGYVFVVTSDIQNLHEELKKVIGLTKLIGTGREIVPISENEKEFLLGfeEQVVQMSEGIITGSQVVIHSGPLKGKEGYIRKIDRHKraWLELPLLGGMQNVQVGLEIVCK-
195 UniRef50_B8IE36 NusG antitermination factor... 104 9e-22 1 21.9% 5:159 37:193 ----YAASVAGHGEYRACEWLQQAGFATLAprTAVVRQASSGKRLVRRPVFPGYAFVG-KRPEQSWRDILRVPGVRALVTTGEAPTELPPWMMKMLIAamGAYDRPRPQLAVGDKVRIRDELWQGLIGEVMRAPEGRRIAVLLKAFGKKHVLSVDVDRL---
196 UniRef50_B0P702 Putative uncharacterized pr... 104 1e-21 1 18.4% 1:158 1:163 MAKWYVLQVLAGQETAVRDALHIMGIRAAVPQEERLLRKNGGWTSRIYTLFPGYVFLSLEYSAENYYRVKAVPHVLRFLGFSgsPSCLTHLEAEWLRLLSNGGEPLKPSRvpDGSVRIMEGVLQNFPVRSIHFDRrrRARVGITLCGEPKILTLSMGS----
197 UniRef50_C3MAS1 Putative uncharacterized pr... 104 1e-21 1 19.8% 1:162 1:168 MGHWYVVRTRAGQQQKATREFEDNGVTVYCPMLRRETRhsKKWLMKECPLFTGYVFAYLRISD--FGTLREMRHVLSVLAdgGTPIPVAGNIVEDIRDAQERGdpPVRRLKAGDTVQVKDGPLTGHYAAVTNIVGRRAIKAFVEIFGSLREVEIGLESIRRV
198 UniRef50_C0ZGR2 Transcription antiterminati... 104 1e-21 1 16.9% 2:161 1:175 -MKWYAIFVESGKEEVVQKYLreQSLKSIVPKRLVPEKKSGIVYNVLKNFFPGYVLIQTEMTNEMFHKIKKIPRSLRLVNNGSYYSqiEEKEITPILQLMGNGEvySKVYLENSKVIVESGPLKGLEGIIKKVDKHkrAKIFLTFMGVEKTIDVGIEILSK-
199 UniRef50_B8IIP1 Transcription antiterminati... 104 1e-21 1 19.4% 3:162 58:230 --RWHLVDCRAGKARQFADALAAGAIPALRLSEEVVRVRSGRPIRTRMPLFGRLLFVGLDpeDAHWLRDKYDREIKGVRFRDEKFMLVPGRELDQFTGVLGGDVPpvEDFEIGEAVRVADGPFASFSGLVEEIDAeqNLKVSVSIFGRSTPVTLEPTQVEKL
200 UniRef50_C2NS75 Transcription antiterminati... 103 2e-21 1 19.5% 1:159 1:173 MksWYALCVRSGYEDLVerDLNETLVSVLVPKKTVPEKRKGHFKWVTRKLLPGYILINTSMDAKMYYKLKEIPNCYNFLndDIYFLEIPDQEITPIIQLLNDRGTIeeAYFEGSKVIVKSGPLKGREGIIRRIdrKKRAKLLLNFLGDTKMIDVGVEFL---
201 UniRef50_O84322 Transcription antiterminati... 103 2e-21 1 17.3% 1:162 1:175 MFKWYVVQVFTAQEKKVKKSLEDfiQQIILPSENVMEVKKGEHKIVEKYIWPGYLLVKMHLTDESWSYVKKTQGVVEFLG-GGAPVALSEEEVKNILADLEEKkvQKHKFEVGSQVKINDGVFVNFVGVVSEvhDKGRLSVMVSIFGRETRvdLEFWQVEEV
202 UniRef50_A6DRM3 Putative transcriptional ac... 103 2e-21 1 25.2% 3:161 5:166 --DWYCLYTKPRQENLTAQSALDAGFPTFNPKIEVRKVRRGKATYVHAALFPSYVFIQA--NEGNLDKARYLRGVNRIIGFggESLKIPAVILETLSTFLEDNVYKHDmlKDGDKVQVLDGPLKGVEAIFKklKDGERAVVLFELFSNYQEAKVNIEDLIK-
203 UniRef50_O67757 Transcription antiterminati... 102 3e-21 1 16.0% 32:162 116:248 -------------------------------KITCKENKTEAKIVLDNKIFPGYILIKAHMNDKLLMAIEKTPHVFRPVMVGGKPVPLKEEEVQNILNQIKRgkPSKVEFEKGDQVRVIEGPFMNFTGTVEEVHPEKrlTVMISIFGRMTPVELDFDQVEKI
204 UniRef50_B7AH17 Putative uncharacterized pr... 102 4e-21 1 18.1% 2:161 8:170 -RHWYAVYVRHNTEFRVESWLREQGIEIYLPVQDVYREHAGKRIKVTKPVISGMLFVCLSRPELT--IVEHAPNVHHFfrGTNAPLIIPDQQMADFRFMVDLSDTSILMVnpGTMVTVAKGSMQGIRGEMVKYESKYYIAVRLQELGCAL-VSVPVSYVRR-
205 UniRef50_Q7D1F8 Transcription antiterminati... 102 4e-21 1 18.8% 3:162 14:188 --EWFVVETKHKAEKAVEDALRKAGVKVFLPLETitVVRGRIIPAVSRPLLPGYVLVNIVYSPAAVCGIARLEGVAGFVGGMVHPHRVSDEEMNRFKAFGDDETAPdeQFKRGDKVRFVLGPFASFGGNILKLRKDRAvvVAVDVFGKVSTIEAPLALLEQL
206 UniRef50_Q4A951 Transcription antiterminati... 101 6e-21 1 14.2% 1:162 3:188 IYKWYMISTISSKEDTAISLLKNRIkeHfvPYYEENPNKPGEKKLKYRNLYKGYFFIKMNMVDKAWFVVRNTQYVTGLVGsgTKPTPISPRQFERMRKKWDQQILNFQqwEIGDWVKVTHGPFSDDFGKIIEMNVTKtiTVELevFGRRTPATFEYKNLKKV
207 UniRef50_A6UA20 NusG antitermination factor... 101 6e-21 1 18.2% 4:162 52:219 ---WFALRVWTGREKTVEKSLDIMAVRSLVPMRKGPDLRRRGRViqMMPVIHGYVLVQMMALSEYLAGLLGVEHVIDVLGGCERPMRLSDKEVNRFNGLARNGNFDWERprAGEPVLITAGPFCDRRATVITPSKKGrvVVSIDFMGGEVPVTVPLALLKKL
208 UniRef50_D1AXH4 NusG antitermination factor... 101 8e-21 1 18.6% 1:161 9:189 VKKWYIIHTYSGYEKKVKTDLEKRifRILVPEEKIFEEKKGKMVPVFRKIFPSYVLVEmrVDSRAWYIIRNTNGVTGFVGVGSDPLPMDEKEVEEIFSKMSNEDFQEkeYEVGDYVKTLDG----IEGTVEHIDyaKQIKIVIQVGSRPTTLTLGLNEVTK-
209 UniRef50_A4YU22 Transcription antiterminati... 101 1e-20 1 14.5% 4:162 31:199 ---WYILRTHPHCEAKVMKAFRLRNISAYLPVMTvrRMRRgeRRDVVSPLILGAVLI--PDFEERWQCWRGVDGAVGLLRFGEWTPRLTPKLFQDIRKIEDIANTPKSkfEVGQLVRVLSGPFRYFSARVERIDSRGRLSVGAEIFGRITPIDIDEGEIEAV
210 UniRef50_A7Z6E4 Transcription antiterminati... 100 1e-20 1 16.9% 2:161 1:175 -MKWYALFVESGKEETVQKFLreQALYSIIPKKKVTERKAGIKYEALKKMFPGYVLFKTKMTERTFHKIKELPISCRIVNNGAYytTIKDEEILPIIRLIGEGDtySKVYIENSKVTVASGPLKGMEGIIKKIDKRkrAKICLSFMGLDKMVNVGIEVLSK-
211 UniRef50_B8IAM8 Transcription antiterminati... 100 1e-20 1 19.4% 2:161 90:254 -RRWHVMVAKPRFARRAAKDLTKAGIPAVLTDERVevEESGRRRIVKRPLLRRVLFVGLPRCAAPEVVHRETYFVRDAVRDggRAIQVPADQLRRFVRALADteRDPNAFEPGDEIRIKSGPFASFHGIIEDAdaTRRLKVAVEIFGRPSPVGLDFSEVER-
212 UniRef50_C5CGE4 Transcription antiterminati... 100 2e-20 1 21.8% 44:162 226:353 -------------------------------------------KITRTRLYPGYIFIEMIMTDETWNLVKSTPNVVNFVSNGGQPIELKPKEIKALLRLVGLEekVEVDFEVNEMVRINSGPFEDFVGKITEIDPERqvKVVVSIFGRETPVMLNLSEIEKI
213 UniRef50_B8I511 NusG antitermination factor... 100 2e-20 1 19.4% 3:162 16:187 --HWYVLFVKSGREHRVEQYLKKIviNPFIPLHEFLFKISGTVKRELKPLFPGYVFIESDMAGQEfnKIYLLSDIVRILKYSDTEIAVRDSEKQMLLDLCNNEHCIESsvIKGDRIYITNGPLRGRESIIKKVNRHKraLVEMEFMGDKRLVSVALEIVEKV
214 UniRef50_A5CC98 Transcription antiterminati... 100 2e-20 1 18.0% 2:162 9:181 -YQWYIIRT-SGSESSIKQTILEKaeEIIIPGIQVVKMKRGKAINVNKKTMPGYILIKMDMIDQVKDFMQKVVKLNRFPGNESKIVQVTEKEVQEMMVQLENKAQDpeKYQIGEEVRVNDGPFETFVGRIEEVDYAKKikLSISIFQRSTELTVDFSQVEKL
215 UniRef50_C4FB35 Putative uncharacterized pr... 100 3e-20 1 16.2% 14:161 13:169 -------------EDRAAALIAkaVDDCFVPKREVTHRKSGQWHRILEKLFPGYVFVRTSAPKQIREALGRVPAFTRMLTsgDTCLPLTADEVAWINAITNVDTHVMEmvIEGDCVMVIRGPLKGHEARITRIDRHKRLavDMDMFGRHKAIRVGLEIVSK-
216 UniRef50_Q2RYZ3 Putative uncharacterized pr... 99 4e-20 1 19.7% 4:160 116:275 ---WRVFYTRARAEKKCETRLDERRIDVMVPKKTEVRQWSDRTKEITEPLFRNYLFARVDEKDRLR--VLRTNGIVRCVHFDGEPARLREETVDRLQKAQAVPERLStrPAVGETVTITGGplQGLTGKVLQHRGQTYLLVQVRAVRQAVKIEVAADWVQ--
217 UniRef50_P29397 Transcription antiterminati... 99 4e-20 1 21.3% 36:162 217:352 -----------------------------------TRKEIRIYKTKRRKLFPGYVFVEMIMNDEAYNFVRSVPYVMGFVSSGGQPVPVKDREMRPILRLAGLEEYEEKkfKVGDMVKIISGPFEDFAGVIKEIDPERqlKVNVTIFGRETPVVLHVSEVEKI
218 UniRef50_B5CXQ3 Putative uncharacterized pr... 98 8e-20 1 16.2% 3:162 8:171 --HWYAFYVRMHHEKKTAEKLEMLKVVHFLPIQEVIRQWSDRKKKIKQVVIPMLIFICTD-EKGRIELLQNLPSLTGClpATRRPAIIRNEEMEKFKFMLDFSDeqSEPLAPGEKVEVIKGSLKGLQGELVELEDHSQVMIRIEHLGYAT-VEIPVGYVKKL
219 UniRef50_A8S2H9 Putative uncharacterized pr... 98 9e-20 1 14.8% 2:156 1:154 -MLWYVVQVRTGEEKDIAAKLTDMGFQTLAPVENRPVRSGGAWGTKEYVLFPGYVFLQMDYNAGNYYRLKAVPGIVKLLSGTLTY--LEAEWIRLLAGQGGRPLEPTLMRETEEGLEIETGILQNFKSRIIRMDKRsrATIELSICGEKKEVQLGI------
220 UniRef50_B8IEU5 Putative uncharacterized pr... 97 2e-19 1 16.8% 2:162 5:170 -RTWHLVRTAPSMMGRALDTLKEQGIPTVVPRTVAVGHREGRPYLRRAQMFHRTVFVGVEGAADLDGKVPTARGVTRVLRNPTrpMTISGPDMAAFVAAIgtEKRKPAGIAAGDRVVVQAGPFASFPAMVEEVLPNERLKVAVQIFGRATPFECGHADVRPI
221 UniRef50_B6GCE7 Putative uncharacterized pr... 97 2e-19 1 14.6% 4:161 37:203 ---WYVVNVPTGRESALCKVIERivRECFSPLYSTQIKRGGEWLDVEKTLLPGYVIVATEQIGRVKRLLREVPEYTRVLNMGESFVPLADGeiDAFTRKGERCVPMSMGVMEGDHVVVVSGPLLGREACIKSVNRHRSIavELEICGRRVTTKVGLGIVSR-
222 UniRef50_D1PRH1 Putative transcription term... 97 2e-19 1 16.2% 5:158 4:163 ----YVLQVITGREKDICGRLRKAGIPAYCPRAVRQIRRGGRWQEQTYTLYPAYIFVQCERVVDVYYAVRREDGVLYWLGAtgTPEPLSADEEANILWLAGDGPQPVSkcRADGSLDFTSGPLkeLEALRSVFRRERRATAVLPLHGKEHKINLSFEI----
223 UniRef50_B9JXL7 Transcription antiterminati... 97 2e-19 1 19.7% 3:159 51:218 --RWVVARCKSGLEQVIRDALAEQGIDCWCPCERRRLPPRRRKpvVERPLFRGYLFVRVIPDNEAYAGLLLASRLQSLMGQDGKPYLMPETLMRQlrRHMDAGDVPPMPDMLGKQVTIRSGPFADFVVTVRKvsKRGQVVVDVPMFGGMSEVTVGVEAI---
224 UniRef50_A7FC44 Transcriptional activator n... 97 2e-19 1 37.9% 1:161 1:146 MKNWYLLSYKYGQVNRVQFGLDRLGVNSFSPSIQVKKVRsgTIRLVNEPMFPTYLFVEFDIESIHTTTISSTLGVNYFVKFGTEPKPIPLSLIHQLMNRSE----------------CSSQRNEEIDEIATIPDKKLRCALFIKLITQ-IPDSFEQNSLIK-
225 UniRef50_Q48MX6 Transcriptional activator R... 95 5e-19 1 25.0% 2:149 42:187 -KEWYLVQCKSGQDSRAEENLTAQGYANFRPTINASSESRSVNTKHNSPLFPGYLFIHLSASD-NWAPVRSTKGILTIVKFGGRAHAVRNEIIQDIKTRAESLNYSHSSHSEKDSAPLDN-RGSEISDILSAKSHEERTLLLVGFLQRE-------------
226 UniRef50_B0K4N5 Transcription antiterminati... 95 6e-19 1 17.5% 1:160 1:166 MKKWYVIFTRSGYENKVRDIIekEEVKLLIPKRKIIERVKGQPVEKIKLLFPGYVFVNAEMSDDLYYKISEVLKRGIFLKEGKRPAFVKEEEMKIILSLTKNSDLisKGIMEGERVKIIEGPLKGYEgiKKIDKRKKRAKVIFSIAGELKSVDLAIEVME--
227 UniRef50_B8INV2 NusG antitermination factor... 95 6e-19 1 16.5% 2:159 6:175 -KTWFVVQTGPARERRVVELLAREGADTWLPLFRVTTVRRGRKVDDFEKVFASYVFAGLDEETMRRrvLFDCDHVLDVLGVD-RPLPFPADALQVLADRLAGHNRDEtkIQVGEMRRIINGPFMSFFAEVEEVLSNGIIKAGVRIFGRITPVEFTPDQL---
228 UniRef50_Q7UWN7 Probable NusG-like protein-... 95 1e-18 1 18.9% 4:162 26:183 ---WWLLYTKSRQEKAVIRKLRDAGVPHYAPMVkrFRSPAGRMRESFVPLFSTYVFLRGD--DQARYEAICTGSVLKASEIVQVPDLIEDLQQIRSLIVMGVPLTIESQLQPGEHVRVKNGTFAGYEGTVIRRENETRLLVFVRFMEQGVSVKLEDCQLEKI
229 UniRef50_B0MWZ3 Putative uncharacterized pr... 94 1e-18 1 18.2% 4:162 10:178 ---WYALKVFYNRVFELEKQLSQEGVRSYIPLLHEDTVAGDKKIRKRKPAVSSLMFIRQslLELQDRMKASCPFMAYFDRETKKPAVIPDREMELFMQITSADTSDLEYfrSGDKVRVTGGPFKGAEGYIKRIRGNRRLVVALEGIIAVATTYIPGRFLEKM
230 UniRef50_A6E8J5 Transcription antiterminato... 94 1e-18 1 21.3% 1:141 11:153 VQKWFAVYTRPRWEKKVEQQLKMQGITCYCPLRKVQSQWADRIKVVELPLFSSYVFVCIHPREEL--NVRLNIGVVNFVYYMGHLAEIRHSVIEEIKSNLEkeIVSMRDLEVGDRVRIKAGLMGEQEGKVLQVRGKNVLLV---------------------
231 UniRef50_A5IXI2 Transcription antiterminati... 94 2e-18 1 17.2% 4:160 6:195 ---WYMISTVSGKEDKVVESLKNRIveCflTTKEAEKKALGeyKVKMSNMYGGYIFINMDMTDKAWFVVRNTQYVTGLIGSAgkPTPVTKKEIDLAFEKEKQLIEDfdKFTVGEIVEIIDGPFKGTIGKVLEANEshKVTVEVEHFGKKVPTDFDYSVVE--
232 UniRef50_B3PLY8 Transcription antiterminati... 94 2e-18 1 12.0% 3:160 11:194 --KWYMISTVSGKEDNVVESLKNKIseCfmpkELEKKSKGEEYKVKYLNIYKGYIFINMIMTDEAWYLVRNTQYVTGLIGSSgkPTPISTRNFEKMVQKEIALAEkeTVFKEGVIVKITSGIFKGEMGEIVKNNdtQKAFVNIEQYGRKVPTEIDHADLE--
233 UniRef50_A6X1C2 NusG antitermination factor... 93 4e-18 1 15.7% 4:162 51:217 ---WLVLQVMSGRELSVREALGKENIEVLVPMKMGPKIRRQGREikKQPVMNGYVLARCMISNECLAGLLSFENVVSILGGYETPFLVSAEKVFVFRAKAEDGQYDYEHFHRkkWARVADGPFAGCRAELVstKGNGLVVIEVSIMGRPVAMTVPIAILEPL
234 UniRef50_D0I9V3 Putative uncharacterized pr... 92 5e-18 1 19.6% 2:159 4:162 -YRWYAVYTHFNEEKVLRDELLAKGYEVYLPERKLWETLGNRRRVTYEPLFKCHLFVRTTPEGLK--NVKQAQGFSHLVRYGKYVATISESHIIKIKTIleDATSVSNSNVEGLAVAVVNGPLKGMIGVLPAGEGERPIAMEIGQLGYSVNVTVPMDTI---
235 UniRef50_UPI00016C34F5 transcription antiterminati... 92 5e-18 1 15.7% 3:161 12:172 --RWAALRTAARWEKAVTEQLAAAGVPVFLPLLTRVSRTKSKTQTAQLPVFPGYVFCGEREYRDSTRVPPSCRKLIAQLLRAPDPDQLKDELRSVADLLANRQLLQERVyvIGDTVRIVGGPLAGSLGTILRLKptRRVLIEVSFLGARMEATVEERLLEK-
236 UniRef50_B9YBN1 Putative uncharacterized pr... 92 6e-18 1 14.4% 2:161 1:169 -MSWYFIETERFQEEQVKETLLNSQFDAFAPKKEMYFKKGDLTTLTLRFLFPGTVLIHDPASPPQFAKkrNQPGSEGIHREADAYFSLASDEKETLEQLLNEKkqFSTGIIRNKELHVLKGPLQGHEKEIQKIKRHQRLATliKLCGQTIPLILGLEVIEK-
237 UniRef50_B6GA74 Putative uncharacterized pr... 92 6e-18 1 17.0% 3:161 4:171 --QWYVIQVMKGREDSMASLIGRVvqEVFSPKYETEIKVRGRWVPVQKTLLPGYLIAVTNDPEGLEAVLRDLPEFARLLAQGNEFVPLAPAEVEVIGSFTSPGKRVVPmvKDGDRVVVTGGPLVGHEAMVKEIWRRKSIAIlvNMCGRVVTTRVGLGVLSK-
238 UniRef50_Q73PT3 Transcription antiterminati... 92 7e-18 1 13.8% 2:161 1:171 -MDYYVVQVSTGKEKNfkNKFDELSYSIVFPQRILKIRKAGKVTEKQLPVFAGYLFIGTdiSKDLYQHLRKCKGFYRFLPNNQEPKFLEGRDFEILNQFISFgkISQVVFDENDRIKVIEGPLSGLEGYIVRVNKRkrATVCLDMCQTAFSIDLGFEILNK-
239 UniRef50_C3RM78 NusG antitermination factor... 91 1e-17 1 15.2% 1:158 1:164 MknWYVLFALVAKENKLCSVLRRKGLDAFIPKIEYY--RRDIKGNTLKMLFPGYIFVRSEMKQSDFDNleQRDGLIKQLKDDGV-TALRDEEIEMFNKLLNSEGILEMsfIEDNKAKVIYGPLIHYQDHIVKIDKHNRIAIliEFLNRHILAGLEIKS----
240 UniRef50_D0D588 Putative NusG antiterminati... 91 1e-17 1 19.3% 4:153 45:207 ---WYALLCRPQQERHAESWLAARGVYAFHPVTSRRTRVRGKLREYERRYLPGYVFARFDGIPIPHRVLTS-PFLTGAlrSDGQWGVLGPKRLAALHEMRARDLRQEDERQEQkrAMFRAGPFEGMSCEVVEIDAAGGVKVRFDLFGRENSVT---------
241 UniRef50_B0UIZ3 NusG antitermination factor... 91 1e-17 1 16.0% 4:159 52:215 ---WLVARTRPRWAPRVVRDLAALGLCAFEAREEVERvpDGARRRVAVPLLHRLVFLGL-RDDADLARAEAHPGVLRVLFREGRAVTIPAPILQAFADAleDEAVEAVLLALGDAVRVTRGPLAALRGTIEAVDprRRYRVALGLFGRATRVDLAAEEV---
242 UniRef50_Q5LG31 Putative transcriptional re... 90 2e-17 1 15.7% 3:161 16:173 --HWYLAFTASRAEQRVKQELDQRKVRNYLPLRKITYQWQGRSREALCPQIARCVLIWTSLSD-----IRQLSGISGLIIPQNIwyRVPEWQVEsfSQMDTAVEWIPDCLESATMVRVTGGPLTGLVGELDTSDTGFRIRIRFHSMG-CFRVAVPEEWIEK-
243 UniRef50_A6TKC4 NusG antitermination factor... 90 3e-17 1 14.3% 7:160 1:159 ------MHVKSNEEMKAKKLVEKEiiKVIVPQRIIPEKRQGETRHVKKILFTGYLFLNVELDVDTYYKLKRIPSIHRFLGL-EKPEAIPLEEMQRVLRLCNQGelSKVIVKEGNKVQVVSGPLLGMEGHIIKVDKRkrAKVCLSVLGDAKTVDLGIEIIK--
244 UniRef50_A6L134 Putative transcriptional re... 88 7e-17 1 15.7% 2:160 7:174 -MQWFAMRATYRRGMQIKGLLDQKGINSFIPMRYEIHLKNGHRRRELVPVIRDIVFVHTTQSELQRIKYGIPYFQYMMDIRNGEKIIVPDEQMRRFIAVAGTYDEQIIFFSPDekVRITGGQFEGYEGVFVKVKgdRRVVISLQGILALAMATLSPDLIE--
245 UniRef50_UPI000174528A NusG antitermination factor... 88 7e-17 1 25.4% 26:159 7:142 -------------------------VETFCPRIRFQRSTPRGKVWFVEALFPSYFFARFVYSEAH-RAVKHTHNVIRIVGFGGDPAPIPDLTIENLREEMQGAELREVKyeVGDTVEVAEGPMRGLKGVVESlsGEQRVKLLLEFLGRQSLVEVQASKL---
246 UniRef50_B0SHW0 Transcription antiterminato... 88 7e-17 1 17.5% 4:157 13:170 ---WYIVYTKPRAEKKLSELLRKYHIENYLPIRKERKKWTDRFKWIHVPVLPSYIFVRIVFWRDK-NKVLQLPGSVQFVFHKGQPAIVEQNDLDVLEkaESLKMNPELLLQKGKLVRIIDGSFVGKTMEIIKVKNKTLVVCRIPGVETIFSYEINMD-----
247 UniRef50_A7UZ21 Putative uncharacterized pr... 88 7e-17 1 19.1% 4:160 10:175 ---WYAMRATYRREPDAMHLLKKENLGCFIPMQYKICIKKGKKVRALVPVVHNLLFVHARPSDVQRVKSQVTYLQYITDTRSGQKIIVPDGQMQRFIAVSGTYDDHLLYFQPDekVRITGGEFEGQEGVFLKVKgdRRVVIEIQGVIAVAMATIHPDLIE--
248 UniRef50_Q1VSS9 Transcription activator or ... 88 9e-17 1 18.7% 2:151 7:156 -KKWFVLYTKPRGEKKLSEQLNRSGIEAYCPTRTEVRVWSDRKKKVEMPVLPSMLLVKI--ENKQRAKALESPLAIRYLFWNGKPSVVTQVEVDTLRSILGDSKFEShqLRPGQKLDMTELGFENIEGTVQYVNKKE-CWVVLQGIGYVVK-----------
249 UniRef50_A6L7Z6 Putative transcriptional re... 88 1e-16 1 15.0% 3:162 10:179 --HWFALKVFYNKVFEIEESLKKDDIDCYFPCEDAVVMRNGVRKIIRKPIISSILFFHSTTLRAMEIQRQFTDKVILYTRDKevPLIIPDREMNIFMLVTSSGEKGMEyfCRGERVRVIDGKFKGAEGYICRIKKNSRLVVAIQGVCAVATSYIPQSFIQKI
250 UniRef50_A7V7E7 Putative uncharacterized pr... 88 1e-16 1 23.5% 3:138 67:218 --HWYALRTTYGREKKAYDYMTAKGITAFYPTTDTVKLIKGKRKIVTESRLPNIFFAYGTEEQLKTFVYDNvrFYYRHVHVGRrpMIVPDYQMESLKIICAADaiEVPKFEKGQLVRVIDGAFKGVIGRVARWQGQQR------------------------
251 UniRef50_Q8VSS9 UpdY n=24 Tax=Bacteroides R... 87 1e-16 1 16.4% 2:160 7:175 -KSWYALRITYSRELAFKEYLDSRGVRNFLPMRYEYVFRGERKIRKLVPVVHNLVFVYATRSEVDEMKStsLPIRYIMDRETRQPITIPEVQMRSFIAVAGNYDEQVVYLDPsdRVRVTGGIFEGVEGEFVRIKGDRRVVVSIQGVMAVATAFIHPSLIE--
252 UniRef50_B0VET3 Putative uncharacterized pr... 87 1e-16 1 15.1% 2:160 23:179 -RKWVVVHTKPRCEKKLADYAKQHQITYYLPQYTSKRVYQRRKVDVNKVLFPSYVFVGIDFKGKQELLISG--YTVNFLKVNAQKELIDELQAIYYGRQKNVQMEPGLWLEKGLEVEIVNGPLKGIRGVVEDQSKLTEVRLQVNILKQAVLVKVRTQDIK--
253 UniRef50_B1ZWG3 NusG antitermination factor... 87 2e-16 1 12.7% 4:160 23:177 ---WLVCHTKPRCEKKFAALMAAERFEHYLPLVDSVRKYRQQTKRFTKPLFPGYVFACVPNEKRAR--IFQQDLLARAIDVDDERRFLRQLDDVRAIVASGYELTVLPLLTRGRRVKIVGGPLHGLEGFVDDPSNPRGVVLSVDVLQQGLLVKLPAENLQ--
254 UniRef50_Q6MDM6 Transcription antiterminati... 87 2e-16 1 18.6% 50:162 1:117 -------------------------------------------------MWPGYLLIKMNLSDESWQYVKNTNGVIDFLG-GDKPTPLTDFEVGEILKDLEDKKrqKHKFEVGDRVKITDGVFVNFIGTVTEvhDKGRLSVLVSIFGRDTRvdLEFVQVEEI
255 UniRef50_UPI00016C58F1 transcription antiterminati... 85 6e-16 1 15.6% 2:161 24:222 -KKWYAIKVQSGREDTIKAAILRKIaqIMVPVEKVIEKKaeRKVERKVKKFQGYIFAELEFNDRLLYLIRETSGVGDFLkdTPVPEPMSDAEVKQMlgPEKGPTKVKVDFEKGDRVRIKEGSFKDSEGDVKDVILPkkVIVTVTFWGRPLDVELEYWQVTK-
256 UniRef50_Q8AAK2 Putative transcriptional re... 85 6e-16 1 17.4% 2:162 14:183 -KAWYAVQTFYCKEEHLGKYLEKKGVNYFIPMRYIeeTLDGKKHRKLTPAVHNLLFIEKEFTEkeRVKDCTIPFLLVRDRSTRRCYEIPDCEMLEFRAVCDPndTVTAEARPGQAVRVIRGPFAGLEGKLTQYKKSYYVVVTLATIG--VMLHIPKWYCEKI
257 UniRef50_A6DPM2 Transcription antiterminati... 85 7e-16 1 25.5% 3:96 6:114 --QWYTLQALSGKENKARQDLERRilEVLLPTEKVTTVRQGKKITQNRKFYPGYLFVNVdmKEDVWHFVKNTYGIINFLG-GDKPVPLSDDEIQIL------------------------------------------------------------------
258 UniRef50_B1C1D4 Putative uncharacterized pr... 85 8e-16 1 14.9% 2:149 1:165 -MNWYVLYTLSHRTQRILGNlkKKELEAFIPSYEVCHRYT--KEITIKPMFNNYIFIKTMLNQEEFNTleDNNGLIRQLKNADTSA-LTKKEIEFFNLVLDSKHVVrhGYQENGITRVISGPLVAYENHIVKVDKhrRIKLGIDILGKK-------------
259 UniRef50_B0NP97 Putative uncharacterized pr... 85 9e-16 1 18.0% 4:153 16:175 ---WYAVRTFNCQELKISDFLKERKKVHFVPMTYVEKEKEGKTRKMLVPVVHNLVFLQKNESRKATLAmcNVPFSVLCDKETKHPCEIPDKQMTEFRILCDPdtHEEAEAKPGKNVRIIHGPFAGITGKLHRARGGYYLIKTLAGVGVMMRIS---------
260 UniRef50_Q2NTN8 Putative uncharacterized pr... 85 1e-15 1 25.7% 1:144 8:147 IMSWYLLRFKATLFNMVFNHLAASGVYYFCPMIETQYRRPDSvrKRLSPVFPGYLFVNLDFDHCHPQKLSAHRHIYGLINFGQGPSPIDDAVIDLLMAKPHIVRKIIDAPRAWKE-------MSELEKIMYICDDEQRIAAFLN------------------
261 UniRef50_D1CTG7 Transcription antiterminato... 85 1e-15 1 22.9% 40:157 4:123 ---------------------------------------RAQHRTVCSAYFDCYLFVSLDIRQQRWPPINSTVGVRRLVMSEHAPLPVPHGVVESLLAATDDEghPKELLEPGQKIRVTNGPFTDQLGTLDYVGRSGAVRILIDIMNRAVPIYIDRD-----
262 UniRef50_Q5LF44 Putative transcriptional re... 85 1e-15 1 20.0% 3:162 27:196 --NWYALRITYGRELALQEYLNSEGIENFIPMHYEYTIKNERRVRKLVPAVHNLVFVRSSrdAIKESKGTTLPIRYIMDREYHRPIIVPDSQMRNFMAVSANYDESLLYFEPSerVRITGGLFEGVEGEFVRVRNDRRVVVTIEGVMAVATTFVHPSLVEPV
263 UniRef50_C6QJC2 Putative uncharacterized pr... 84 2e-15 1 19.0% 2:159 1:181 -MTWYAIRTNPQREFLLAGrlEKKGYdvFCPTETKFRkkKGRRVsvLYPMFCGYIFVGGRF---SWLELMAENYITAAVGFPdrPAPISDYEMAKLREMSGGLIPHRRsfRVGEMAAIAAGPFAHQVAQIAGLHGTK-ARVFLNLFNGTREVEVDLDML---
264 UniRef50_B6TZG2 Transcription termination f... 83 4e-15 1 17.1% 3:160 104:325 --QWWLVRvaPGTdkAISRRYSEVPFKIYNPSIQVKRrkSGAISVKSKPLHAGLVFLHCTLNKELHDFIRDTEGCYGFIGAtkKPKPIPVDEVESIIREEKEEQERVDrfSPGATVHVLSGPFADFTGSILEVNRkkKATVQLSLFGKESFVDLDFDQIE--
265 UniRef50_A6LD20 Putative transcriptional re... 82 6e-15 1 16.5% 3:160 8:176 --DWFVLrtRPNAKRPAYRLLEEKGIEIFTPMRWRLVERKGKRIREEVPLLHDLLFAHTTRTCMDPIVEEISTLQYRYLRGgrKPMTVGHAEMNRFICAVHSDDSPRYFLVEerMIRIEGGPLDGYEGRLLSIRGTRVKRLIVEIPGLLvaVEVDPKYIR--
266 UniRef50_Q9EUG2 Actx protein n=1 Tax=Escher... 82 7e-15 1 25.5% 2:146 1:134 -MKWYVLQFTTTRFAAVFKHLERLNFSYYCPMATEKYRRPDkyRERLTPLFPGYLFIQADFDEVHTTTITGLPHTQRFIAFGGEPLAVPDDEV--------------CNVQKGERNLLNFDEYPRLVEIMMMSEPRMRSMAMLNYI----------------
267 UniRef50_C6ICX6 UpaY n=18 Tax=Bacteroides R... 81 1e-14 1 18.2% 2:160 6:168 -EYWFAARTRKDQELTTRDALEKIGVEYFLPTQFVIRQLKYRRRRVEVPVIRNLIFVHATKEFA--CAIANEYGVRLfdFDTKSMLIVPDKQMKDFMFVMNLDPAAvdCFAVGTKVQVIKGDFCGVEGELASLSNRTYVTIRIRGV-LSASVKVPKSYLR--
268 UniRef50_Q2GD85 Putative transcription term... 81 1e-14 1 17.2% 4:160 12:173 ---WCVLRVRSGSESKVCDLIKSrvVDLFSPALVKFDASASKR------FLPGYVFVKVVPGSAFLSEISVMRSLYgfLNQAGSPKFLSDKDIDEMRNFMLSPEVTPekISVGSRVAILCEYFEACVGEVDEIDErsKAKVKIVFCGQDVVVSFNLDQLK--
269 UniRef50_B7UF78 Similar to transcriptional ... 81 1e-14 1 32.2% 1:146 1:141 MFNWYLACHQPGKEtkAQLELSRLHIDSFCPLIRLSRPRPDRprLIIEPLFSGYIFIQFDPEITHTTKLTALSSVSHFVKFGCDIRPIPKTVIESLMKL-------PLCPTEQD---VIAGRFKeiVAITRVSNKHERTVMFLALM----------------
270 UniRef50_Q10BA7 Os03g0825500 protein n=3 Ta... 81 1e-14 1 20.0% 3:162 105:328 --QWWLVRvaPGTdkAISRRYPELSFKIYNPSIQVKKrkNGSISTKSKPLHPGLVFLYCTLNKEVHDFIRDTEGCYGFIGAtkKPKPIPVEEVESIIREEKEEQERVDrfTPGASVHVLSGPFEGFTGSLLEVNRkkKATLQLTLFGKESFVDLDFDQIEAV
271 UniRef50_C8WIA4 NusG antitermination factor... 81 1e-14 1 19.7% 5:161 9:172 ----YVLQVVPGRERAVAERVkeLVRDCFALSYCILKKNQGVWRLLTETMFPGYLFVASDDIEAFEKTIKRSTAFARLLGAERRAFALRPEevHDFGGPSHVVGFSRGTIDNGRTI-IDEGPLRGHVDRIKKIDRHKRIAYliGLLDQKQ-VRVGLEIVRK-
272 UniRef50_B9QSZ2 Putative uncharacterized pr... 81 1e-14 1 20.6% 3:162 30:200 --DWIVVRSNPNCESRAAESLSAAGLIAWLPMLPVLRKNSRTRNekSRPLCTRYLFVALDRYkqSTSEVVVCDGVEKVLSFDerPHIVPKAQMRVIVEQceGNLSKVKHFDIGAVFGLLADEFDGVTGTVTGYDEAKGIvgLVPMFGREMAVKVAVDKVKAV
273 UniRef50_B1AJM2 Transcription termination/a... 81 2e-14 1 15.2% 3:160 25:247 --QWYIVTVVSGNEQKVIENIKDkeVKIYEPSEAPRSMKNrcTKIKEGNKFNGYIFLKAEMTDQIWFLIRNTQMVTGLVGSSgkPIPVPEDKieNIEVIELHEDENFTNFEVDQEVKIIADTFFGEIAKIAKIDQNKKIavEFEFFGRINTLDLNFNDIQ--
274 UniRef50_A9BF38 Transcription antiterminati... 81 2e-14 1 20.2% 49:162 231:352 ------------------------------------------------NLFPGYVFVEMMYIKETEELVSNLPYVSTILNIGGKPVKLNKNEVRFVLRVMGEekEVRTDFELGEHVKIINGPFEYFTGKIKDFDLEKqvQVVVTMFGRETTVTLSLGEIEKI
275 UniRef50_B7QPX7 Putative uncharacterized pr... 81 2e-14 1 18.0% 21:159 65:214 --------------------LQKAGFEVFLPIKKEWSRVNreQKLKCRPAMEGWLFVGWAAGQARFHELMALDVVSGVMGAGGQPVRISDAKVrrLRRKASNVEAEPVRFSVGDLVRVDAGPFEGQTVSLLDVSG-GSARAVMTLLGKDVEVDLEQEFL---
276 UniRef50_B5CYV1 Putative uncharacterized pr... 81 2e-14 1 18.4% 3:160 7:173 --KWFVMrtRSNAKIPAYQMLDDMGIENFTPKVTKIVTRNGKRERKELPFIHDLIFVHSSRTVIDPIVERVHTFQYRFLK-GREPMIVRDKDMASFKQAVEssPQDITPCMFKRKIRIIGGRLDGCEGYLLTVRGSKRKRLLVELPMLItaVEVEPEYIQ--
277 UniRef50_D1N7B2 Putative uncharacterized pr... 80 2e-14 1 18.5% 17:162 2:152 ----------------VAQKLRNAGIACYLPVVPRAYMMHSTKVITEVPMFPGYLFLCLGRFEAADLKIREKKIVKIDLQFDEGREALLIDELHTLQRCEALAKTEPILINpgDKVLITSGSLAGLVTEVVRRDdhDAIIVNVTLLGQHIEYRLPAEKLKKL
278 UniRef50_C3RM77 NusG antitermination factor... 80 2e-14 1 16.5% 1:158 1:167 MMNWYLIFANDNKINDLLLYFNNheMTAFVPKIEKLMKKDGKKVFAEVPMFPNYIFIESEFNSQEFYQikDMDSTMRIMQSDEQKVllANNEKELLESLFNDDhiRSIGVIVDSKLIVQDGPLVGKEEMIKKIDRHKRVAFIGDVFGKTMKVPLEVTS----
279 UniRef50_Q6TFR9 ORF9 n=1 Tax=Erwinia amylov... 80 2e-14 1 21.9% 1:155 1:149 MKNWYVLAFTSNKFGAVERFLKLNKIEFLCPMHEHSYSRPDkiRKSLVPTFPGYLFVYLDFNETHPEKLARFQYIYGLITFSNAPMAVPEVTIQVIAYTCSVVKTASSVK------KIISHDFA---AILLTEEPKKRSVMLLNYLCENHSQSVK-------
280 UniRef50_C9Y5P4 Transcriptional activator r... 80 2e-14 1 37.5% 1:96 8:105 MYKWYVLYCNSQDIQRISRRAEDIGVEVFCPRYIKVTPRTDCrrQEEKPLFPSYLFLRFDVNVVHTSTITSIPGAHGFVSFGAAPCTVPESVITAI------------------------------------------------------------------
281 UniRef50_A7V9P1 Putative uncharacterized pr... 80 3e-14 1 13.7% 2:162 28:198 -KYWFAARTLSKQEFAVKKRIENLnvECYLPTRTVISQLKYRRKRSVVPVARGLIFIHAT--KQSACDIHNVYGVQVfdFSTHSMLVVPDKQMQDFMFVMDLNPEGvePLTVGKKVTVVKGEFSGIEGEIATEANKTYVVIRITGV-LVASIKVPKSYLKAI
282 UniRef50_D0XNC5 NusG antitermination factor... 80 3e-14 1 22.2% 4:156 15:184 ---WFVVITHVNQEKLAKYQLERQGHAVYMPMvpRARMRNGVPPSV-RPMIPRYLFVQVDLDQPGWPAIYSTFGVSEVigEGRRPRAIPTRFIEEIRAReaGPAPVACRFKKGDKLR-WHGPTADYEVVFQQMVDGNRAEVVFTLMGVDSRQVISL------
283 UniRef50_UPI0001C34E8E NusG antitermination factor... 80 3e-14 1 19.4% 2:140 1:147 -MSWYVLYCRPGQETEIIESLKQRlsEAFlqCERLWRAGGGNWKLIRKEMFPGYVFLESEDSEYLSEKLEAYRGIVRVMEEPGYLIPVYREEEERLRRLCGPEHILryGYRENGVNHVVEGPLKGMERQIVKADWHRRFA----------------------
284 UniRef50_Q1QI72 Transcription antiterminati... 79 4e-14 1 13.5% 2:142 4:135 -RYWGACRTFTGREHLVRAKIEEMDRGAFLPTFVRSWIAGGKLSVAERPAVPGYVFFRASQDD--WSPVQDIDGVIGVLANGGRAMRISNDDMASLVIGHAAGAHNRFE-------DCISSPSRGSRRKSRKPRPSKRARLR--------------------
285 UniRef50_C6I4Z2 UpcY n=5 Tax=Bacteroides Re... 79 4e-14 1 15.9% 24:161 2:142 -----------------------QEVDTFLPVQNRVIEREGKRIERERLLLPRMVFVHISRQEM--AAVRSTLNVYDFlrSTGAPTCIPDAQMADFRYMLDYSQDQveSIPKGTRVVVAKGDLQGLRGELVRYNNKYHILVRIDMFGSAM-VTIPASYVRK-
286 UniRef50_B9Y881 Putative uncharacterized pr... 79 4e-14 1 11.6% 2:156 1:164 -MRWYFVEVEKHHEEDVLELMKSSPFEAFLPKKQRYFKKQVLVTWVERLLFPGTIMITSDFPQAEFTklSQHSDISQWIHLEEkyFSLQEDERLFLNSLMNEQHVIptGFLNEKQLIVESGPLQGLESRIKKIDRHQraQVRFQICGQMMLLNLGL------
287 UniRef50_A6LE17 Putative transcriptional re... 78 6e-14 1 15.8% 1:146 2:156 MKKWYALKVFYNRFSEIKATLSRDGIESYIPMKTRSyqPDGEVVIRRVPLVAMLMFLRCDDDYisLNSILDEKAMVYHRPGTQIPASIPDEEMDMFIMLTSSMEDGFEQikNAEKYRVTGGEYAGVVGYYRRIKKNKRLVIPFEGL----------------
288 UniRef50_Q4A648 Transcription antiterminati... 78 8e-14 1 20.0% 3:162 7:199 --RWYLISTITGKEAVIVEALKNRifKVfvPSITKTELNKKQkkVKWKNMFPGYIFVKADMQDLVWYIIRNTLQVtgSGGGGEKPTPVSQNQIRKSLEKEEEAKKLFenLKVGDLVLITDGNWVGNEAVIEKIieDNMAEISFEDFNKKVEFKINLDWLTRI
289 UniRef50_Q7BQV7 Putative NusG-type transcri... 78 8e-14 1 28.8% 1:146 1:156 MERWYLACHKAGKDnkAQMTLERMNIMAFSPVMRAYRPRSDRprPVMEQMFPGYLFIFFDTEIHHSSKIELCPGISHLVRFAGEITPIRDAVVDDVM-QLPVCVQAFSRKNPGKRRwlNHQQRQQIQALVDTKDGDVRSALFFAFV----------------
290 UniRef50_B9HCH7 Predicted protein n=1 Tax=P... 78 9e-14 1 15.9% 3:159 110:337 --QWWIVRviRGDerLLARNFPQMDFKVYAPSVKERRkkNGTYSVKPKPIFPGCVFLWCVLNKEIHDFVRECDGVGGFVGAknKPRPVSDDDMEafQQAKEEQEKADIGFEEEqtVRVVSGTFADFVGSLKKLNRkgKATVVVTLFGKESLVELDLSEI---
291 UniRef50_B9NP65 Putative uncharacterized pr... 78 1e-13 1 15.7% 21:160 63:213 --------------------LRRAGFEVFLPIKKVLRRKNreKALISQPLLVDWLFVGWPVGESRWHDLMELDVISGVMGTGGHPIEFPAARVMSLMRQWGGGHLSSEcfAVGDTARVIAGPLDGVHVRVVDVSGP-TVKAALGMLGSEVVTEIRGDLLE--
292 UniRef50_D1VYC4 Transcription termination/a... 78 1e-13 1 14.7% 4:153 33:194 ---WYALRLFTLKTQQVIDYLEEHHLDYFIPMEYvvEDRKHRVQQKLRPVVRNLIFIKRTMSELSIRKILTEasVIRKSREDSQYYEIPSRQMFEFQAMCNPEIVMRQYLSEAQavYVKYGPLKGLSGRLVRSNKKYFLLKEIPGLGVMLKVS---------
293 UniRef50_C5B0S5 Putative uncharacterized pr... 78 1e-13 1 15.7% 2:160 5:185 -RGWLIVRAQLGRFSQVVEGLKSAGCPVFEARREIRVQTDGKPKVTNAPMMGRTLFVGVEEPEYA-CLLAGLDYVHGILCRGerPAMIPPKMMTEFADhkGVQDFVETLFSVGDEVRISNGAFATFMAKIEGVdkRGRYTVAVDVFGRPVPFEIAEESLE--
294 UniRef50_A4E6I1 Putative uncharacterized pr... 77 1e-13 1 14.3% 27:159 16:152 --------------------------ELFYPQYQTEIKVHGEWVSTTKPLFPGYLICDTADPRTVQQYLLRMDDFARVLSQDGQFVPLAKEeiGSFTNRGDRVVPMSEALKDGDQVVVTAGPLLGHEGLIKTINRRKSTalELDLCGRRVTTRVGLAVL---
295 UniRef50_D1XYZ0 Transcription termination/a... 77 2e-13 1 18.5% 3:153 18:180 --SWYAVRLFTLRLKEVKAYFEALDYECFVPMQYviEKPEGGVKHELRPVTHNFIFVKQTMSEASFKkaNFKINVIRKVDDVTQFALIPSKQMYDFRMMCNPEieREAQMKAGDPVLVKYGAMKGMTGRLVRSNKKYYLLKEVPGMGVMLKVS---------
296 UniRef50_C5VMP2 Transcription termination f... 77 2e-13 1 16.7% 4:153 18:179 ---WYAVRLFTLKLEEVRTYFTSHGLECFVPEQYviEGHDGKPHSILRPVVRNLIFVKKPGEDISFQKinYKISVVKKAKDSQEYALIPHDQMYEFRLMCNPEITMRKFlkAGDEVLVKFGPLKGMIGRLVRSSKKYYLLKEIPGIGVMLKVS---------
297 UniRef50_C3RR25 NusG antitermination factor... 77 2e-13 1 12.3% 2:156 1:163 -MYWYVARCKTGRTKKLVSTLNKqnMNAFIPKSERCFGRGETAEFIVKEIYPDYVFIKSDLDQEAFDefKTINGLVDLLEYKDTYPLTSEEQSLLEKLLDNTDTIKHTKGVIVDRRFvtDGPLVGLEDMIKKVDKYRRFATltEIFTGKLLVAIDY------
298 UniRef50_B0ZDY9 ActX n=5 Tax=Enterobacteria... 77 2e-13 1 21.9% 2:161 5:155 -KQFYLLQCSPHFHQSVLLQLSRSGIAYYNPVIRTFYKRRDcyRGQIMPMFPGYVFVLLDFEVVHPSCFTRMKNVYGLVSFGEYPAEVPLSVINEVKEQEKIFSMNLSLMNNSCLAKI-----------LLLADASKRGQVFADYVCNRKYDRLKNDSYKR-
299 UniRef50_A4EPJ2 Transcription antiterminati... 76 4e-13 1 14.5% 4:162 33:202 ---WFVLKVQPMKEFEVEMWLGQqvLEAWLPTNKAWrrGHRRKVQYRQKIAPGYVFACVERRIAWDLLQRRSNgvLGVVGYNGRPLPVPEEQMRAMkqKIYAEAQSVKLVRPGDKARIldGPMCDWVVDVTEVNG-GIAKILVPLLG-EREAQISMEQLERI
300 UniRef50_UPI0001972DAA NusG antitermination factor... 76 4e-13 1 15.1% 4:149 2:160 ---WYVIQTTTGKEEELAGIVRRNVShcFSMKRELLKRLGGRWTAVTETMFPSYVFLETEQPERLFYELKRLPEYTRLLGDNEGCFIPIEKEEENFLNILRRNEKETcdLDEDGGIRKADGPLQFFLDKIVKLNLRKraVVELKVAGKE-------------
301 UniRef50_C3RR26 Predicted protein n=2 Tax=B... 76 4e-13 1 19.4% 2:156 1:161 -MNWYVLYVFSNKTNKILSNlqRKELTAFIPKTEVF--HRQAKKKTTKDMFDNYIFVKSDLKQNDFNDLlkNDGLIKQLENAEVSA-LREKEIEFFNNILDKDNVARVsyQEEGKTIITEGPLLHYQDHIVRvkHHCTAQLDLPFFDRKIILGVEL------
302 UniRef50_B2CBC8 Transcription antiterminato... 75 6e-13 1 34.4% 1:96 1:98 MYEWYVLYCNNQDVERITRRVEGLDVEVFCPRYIKVTPRKDCrrQEEKVLFPNYLFLCFDVNITHTSTITSIPGAHGFVSFGSTPCTVPKSVITAI------------------------------------------------------------------
303 UniRef50_B7C7N9 Putative uncharacterized pr... 75 8e-13 1 13.6% 2:155 4:165 -EHWYVLLTIRSKEEEVCKYleNDGIYAFSPKMEFYHRVS--KQIQQRSLFGGYVFVVSKLsdAIFKKFPLQSVFIHELKYEEEVSALTDEEIRILNMLLDDEKVLRMSylVNNKIHVTQGPLKNMDDYIVKYDKHNRLATllSFLNqkVGVTIP-------
304 UniRef50_Q98R28 TRANSCRIPTION ANTITERMINATI... 75 9e-13 1 14.6% 3:160 5:190 --NWYMISTIPNKEKEVIEAIKNKVveAysAKELEKKQAGDSYKTTKKNMYNGYIFIEMVITNETWFLVRNTENVSGLVGsgAWPTPISKLKFKKMIEEETKKEEEFqkFREGLFVKIVDGPFKNDE-IVYKIKkkKYSILEIESLGKSVDTQIDHKHLK--
305 UniRef50_A6LGY4 Putative transcriptional re... 74 1e-12 1 17.1% 3:160 15:183 --RWFVMRAYKN-EKMAEDRLKDkgLEYFIPKHYAVKTYHGVKSTRLVPVIPSLVFVHASHSQITEFKKRylQFAMWKKSTGMEYITVPDDQMDSFIQIASLYEKDTAYYKPDerVCIHGGKLDGVKGVFMRVKGkrRVVVMLeiMG--ISAEVHPDLIE--
306 UniRef50_A8T9L1 Putative uncharacterized pr... 74 2e-12 1 27.8% 1:97 1:102 MKNWYLVYCNVKNSRrlIRFLNSFGVEVFNPIMTYYKARkgKFRKQTKSLFSNYMFIQFDCTKFSFSKFDNIEGISYFLRSSGQIATIPEPLIENLR-----------------------------------------------------------------
307 UniRef50_A4E6Y7 Putative uncharacterized pr... 74 2e-12 1 14.0% 3:138 28:171 --RWYLVHTPNGKERETCEKVRCIiqDAFVMQKEFWFKRDGAWSLQTKPMYKEYFFVATHDAAALDRALAQLSFGCRIAGSREryMPMPDDAQDWYRSVLDEDGVVRNSviEDGVLHIEQGPLVGQEARVHKIDRRKR------------------------
308 UniRef50_B1C0R1 Putative uncharacterized pr... 73 2e-12 1 15.5% 1:155 4:166 VMYWYVIHAKvrGSKIVKFFNSQKGVDAFIPKIEKWHNVKSVKDYVIKDLYPDYVFVKSDMDNEAFNkfESIEGFGELLEYEGVYALKDTEQDLMEKLFNGGHIIKRSIGNIVDKKLIVdgPLLGLDDLVVKINRHHRVATltEFFDKKIMVPLE-------
309 UniRef50_B6W2H1 Putative uncharacterized pr... 72 7e-12 1 14.6% 4:160 12:187 ---WYVMRVYKN-ENTAEDRleTYGLEYFIPKQKVLRTVKGKKVFFMVPVIHSLVFVHASHQKIVDFKHNYYyfVTWKSGGELVYLTVPDEDMTNFIKVCKQADEEVHFYKISerVRVHGGPFDQVEGYFIKvkKRGRQLVVidLL--AVSAEVKPEYIQ--
310 UniRef50_D1W4R5 Transcription termination/a... 71 1e-11 1 9.4% 4:152 30:190 ---WFAVRLFMAKPQLVMDYLTEQQLHYFIPMEYvvEDKDHHIRQQLRPVVRNLVFIKKSKPEKarQLLMDAPfvIRKSKDDSKYYEIPAKQMFEFQAMCNPEIAMRKFLSEEQavYVKYGPLKGLSGRLVRSNKKYFLLKEIPCMGVMLKV----------
311 UniRef50_A6UAQ8 Putative uncharacterized pr... 71 1e-11 1 12.9% 3:149 5:167 --RWYAIRTAPGyeSIIERNCRKDGFDIFMPSFYKELKHHRTNEIIEkpFLVGYAFVNLPR--LNFEELRRVDGAVCFLRGAngPLEFPSATIEALYFAEHERRQAFLYEQHCRKENERHEQIQHLRGQLRKILPKGR-KARVSMVDQA-------------
312 UniRef50_Q984H9 Mlr7998 protein n=1 Tax=Mes... 71 2e-11 1 13.5% 14:161 20:195 -------------EIVAERSIRDAGFECYYPRMRKEIIHHRTNVRIVrpLFTGYIFVALPSANGEY--LKDCDGLGRLLSYDgkPWQVPTGAVESYMRAEAdrETIAMTFPEGQAIRVkkHMLAGFHGEVVSVTGRGTVKSMIELFGRLVAAEFDADDIEP-
313 UniRef50_C3M8G1 Transcriptional activator a... 71 2e-11 1 30.1% 2:137 3:141 -KKWYLTCHKSGCSnkAQQALIQIEVHSLSPSIQTWRQRLDRkrAVIEPLFKGYLFTCFDPEKIPTRKIEHCAGISHLVRFANTIVPIREAVMQEIMRF-PLCMNDETRTNHKITTSLKESQKEQIKNIVQKKRRTR-------------------------
314 UniRef50_C4UKL3 Transcription antiterminati... 70 2e-11 1 20.1% 3:146 10:161 --SWYLAQYITGGKNREKlwLCEQHITPWTPLTVRTIRRTDKINCIRkpLFPGYFFLKANLATQTVDNIRRHSAFCGFVMNGPQIAPLRPLIVEGLMKCHPDPTLSPEALNELESawLTTTQYQYLLSIEQDSRPVSRVTLLMKLV----------------
315 UniRef50_C6IMS6 Putative uncharacterized pr... 70 2e-11 1 12.2% 3:150 44:199 --NWCYLFIHHTKVNAVNEKLKER-YCTFIHKSVVYKRKNKRIAKDEKPTISGLVFVQGESDDIQSFLCENFFGLYLvdCSTGKIAVIHNNVMQSFMQVSQVEPARIRFMPhnTLVRITSGPLTGLEGYRIRISRDKCLVTSIGGMTVAI------------
316 UniRef50_A9NQH7 Putative uncharacterized pr... 70 4e-11 1 17.2% 3:136 80:240 --QWWMLLVPRNSERLVAEDLSKaeFQAYLPEIPSRRkkNGSYSESKKRMFPGYLFIRCPLNKEIHDFIRNTPRVRGFVGRKvkPKPVPIAEMEETFRKVKEEQEAYDIEIQEELLkiGQDLLEDLEGTDVRMKKD--------------------------
317 UniRef50_B3JEC4 Putative uncharacterized pr... 70 4e-11 1 14.5% 4:162 32:202 ---WLPLQTVYNKELTVAAYLKEQGIEHYIPMTYELRdrEGECSHVLVPAIHNLIFIHCPY-DANwqFASEAPLPVYFlrNGNDYCTVSERDMQNFMHATNPDIQG-TRFIDSEKLrvRRGPLYGVTGKFLRYGGRHYIA--IEMPQSTALLKVSYTWCETI
318 UniRef50_Q1GII5 Putative uncharacterized pr... 69 7e-11 1 18.1% 1:160 1:190 MTNTYAINTTRGKEFAVRDDLKAMGVNPWVPVRLGSRYVKEKRSAvdAAYVPKLMFAVIPA--IIWRDVLEHKHVIG------KPVALSRLDIEGIPGHVKKSteYQCQFKPGQALELLCPPWEGFSATFAKvdDYAKLRVELEIFGRVTPLDVDPDRVK--
319 UniRef50_B9XD13 NusG antitermination factor... 68 7e-11 1 29.0% 4:103 8:107 ---WYCARTKPKHEHIAAANLLRhnVEVFNPRLRVEKATRRGVIRVSEPLFPCYIFVRCVIEEKL-NDIRYANGISTIVHFANRIPHISDSVVVELQEHFKEM-----------------------------------------------------------
320 UniRef50_C3Q0J2 Putative uncharacterized pr... 68 7e-11 1 19.6% 3:160 12:180 --HWYAMRDLKRRHAkaYKMFENLKVQCFTPMVHRLVVVGGKRVDQEVPFMQDLLFVK-DTREHLDAIVESTPKlrYKLGVQHTPIIVPVADMERFIKAVEASDNPKFyeMRNRKIRIIGGQLDGYTGTLVTTRGSKTKRLLVELPtlAASIEVEAEYIQ--
321 UniRef50_A3DNH9 LSU ribosomal protein L24A ... 68 9e-11 1 15.9% 5:161 10:153 ----YAIRTTMGREIDVALVIESRIMD-----LVKQNRDPGVKAVFVPPGVRGYVFLETSRLASIYRLISELKYVK-----SGQPIKVSLDEVGRLVKP----KPVIEMIKEGDIVEIVRGPFRGMKAQVISIDRNKN-MVVLSILEAavPITVPGDYVKP-
322 UniRef50_Q79JX8 TraB n=17 Tax=root RepID=Q7... 68 1e-10 1 21.4% 2:146 54:206 -RNWYLAQYIpnREH-LFSWLSEQHVLPWTPLILKKVRRTDkyRRHIHAVFPGYFFLKADPERHSFTHLRRHSAFLDFVKMAGEIKTVREDIVQSLMKVYPDPALNPAAREELdtLWLTKARYQYLLRLDAQPLPESRIALLLHLV----------------
323 UniRef50_A2BN62 Transcription antiterminato... 67 2e-10 1 18.5% 5:161 26:164 ----YAVRTVAGREIDVALIMEQRARDQNMPIY----------AIIVPPQIKGYVIVETPAAFYATNAIQGIRYAKGVV-----PGVLRYEDVERLLKPKAVIET----LKPGDIVEIISGPFRGMKGQVVRVSPSKN-EVVLNVLEVEYpiTVPGDSVRP-
324 UniRef50_A9A583 NusG antitermination factor... 67 2e-10 1 16.0% 5:160 10:147 ----FAIRTTGGQEKVVMRLLEAKANANQINIQSVFWVND----------LKGYVVIEAINPSDAYMAVEGVRHIRGQLRGE-----LEFKDIEGYLVKKS----TVSTLAVDNVVEITGGPFKGMKATITRidKEEATVVLLDA-SYQLPVTVDANYLK--
325 UniRef50_B8D5Q0 Putative transcription anti... 67 2e-10 1 17.1% 5:162 15:159 ----YAVKTTLGRELDTALIIGMRIDE-----MRARGEETSIGSIIIPPNVRGYVFIEVERLGELYKVISDIRYIK-----AGRPIKVSYEEFEKLLKPKPVIEE----LNVGDEVEITRGPFRGMRARIAGIDRNKN-MLTVNILEAaiPITIPGDYVKKI
326 UniRef50_A1RX84 NusG antitermination factor... 67 2e-10 1 17.7% 3:160 10:149 --RFYALRVTSGQEYNVAQLLYRRA-------------ASGKYkiLVVPGLKGMVFVESDALYEAQRLAYGLKHVRGVVRGA-----VSLQEMEGLLKP----KPLVDQLNVGDFVEIIRGPFTGMRGRIVGIDKSRnvKVELAEAVFVLPVTINADDIK--
327 UniRef50_B3CAR2 Putative uncharacterized pr... 67 3e-10 1 12.6% 4:122 28:150 ---WYVMRVYKN-ENTAEDRleTYGLEYFIPKQKVLRTVKGKKVFFMVPVIHSLVFVHASHQKIVDFKHNYYyfVTWKSGGELVYLTVPDEDMTNFIKVCKQADEEVHFYKISEINKEKDKP----------------------------------------
328 UniRef50_P96036 Putative transcription anti... 67 3e-10 1 18.8% 1:160 6:148 MRNYYAIKVVGGQEINVALMLEERI---------KTNNIKGIYAIIVPPNLKGYVVLEAEGLHIVKPLIAGIRNARGLAQG-----LLPRDEILKIVSRKTVGPT----VKPGDVVEVISGPFRGTQAQVIRV-EEAKGEVVLNILESAFpvTVPLDQIK--
329 UniRef50_Q131T0 Putative uncharacterized pr... 66 3e-10 1 12.2% 5:160 51:198 ----YLARVQERREAYVARLCKRAEVPFFLPL--VWNRRKNDWAC----LWPGQIAV--SLATKKRLSWIETQSVVTQLERCNSSVLEQMRGIGVFNRRAFDGVLSELGPIAGKTVGEIAGPFSEARSKRISKIDDTRVKYTVEHLGRTVQAILPIEALR--
330 UniRef50_C7XGA2 Putative uncharacterized pr... 65 6e-10 1 16.2% 11:146 58:198 ----------SRRERR-----GEALFEYFSPSYVEARKVGGKMVNTKRPLLYNYVFVHAS-EDEIFRLKRTLP-LYNFlgGRSYFPYLSDREMDTLRWVAASYSNELPVYVPddRVRITSGPFTDMEAEVVVQPGGGHKDVMVRIL----------------
331 UniRef50_B5ZVK1 Putative uncharacterized pr... 65 6e-10 1 14.0% 3:138 28:179 --DWYAIRAAPggESIIERNLRNEGISVYMPAFWYESIHHRTRKVIQrpLLVGYAFVN--LENMNFEQVRDVDGVICFLRSEFGPIRFSGDDLSVIAAEELSRRQEFRRERITRIQKETASQAMQLRGNLRKILPKGR------------------------
332 UniRef50_A7V3C8 Putative uncharacterized pr... 65 6e-10 1 23.8% 1:63 13:75 MMCWHALYTAPKSEHKLMQRLNAAGYTTYCPMQAVFVKWKGHTRKVITPLFSGCLFVAGNVSE---------------------------------------------------------------------------------------------------
333 UniRef50_C9LF34 Putative transcriptional re... 65 9e-10 1 14.2% 3:143 37:186 --DWSYFFTHNARLKHIAQKLKADnfPTFVHQSCKYIRNHDKVCKQLRPTISGLIfvEAYFKERLPELHLACDYATRCV------ARIPHAVMQPFMKIAELDahPFEHYAGSQLVRITSGPMTGLEGYIIRIDRDRKLVLRV-------------------
334 UniRef50_B3JI43 Putative uncharacterized pr... 65 1e-09 1 15.2% 3:160 15:182 --QWFAMSAYKN-EKKAEEMLkkDGLEYFIPKHYAVRVYHGVKSKRLVPVIPNLVFVHASRKQITDFK--KKYNFLQFMMWEkkYIVVPDKQMESFIKIASQYEENTIYYKPEEiiCIYGGKFNGVKGVFmgKRRRRVVVMLEGIMG--ISVEVHPDLIE--
335 UniRef50_Q1GG09 Putative uncharacterized pr... 64 1e-09 1 15.7% 2:160 1:186 -MTWYLGRTTTRheFAVERQLRALGIEAHAPRRIEFKRVGKKrePITSAYLPGYIFAEIPASMFTRAilMAVPAQEVLHHVKPFIAKVKSENADAERIIESRDRAAMCQFQPGEALDVLAGPFAERLVKFTRmdSYPMIEAQIEILGRLTRVKIDPLDVR--
336 UniRef50_A6L935 Putative transcriptional re... 64 2e-09 1 16.4% 2:160 39:218 -KHWYIAIVNNKSEKLCRDKLEKRiyEVYIASQKEmlLPSGKRKQVDRIVFRSIVFIRCT-DVLRRKEIVHLPYIKRFmsGGIRPVaiPDEQMVKLRRMLDDSEEppRPLPLGARVRINGGKLHGLEGNVLEvdGNLNFVIRVDLLGCA-KVNITRDLLE--
337 UniRef50_B9QXN0 Transcription termination f... 64 2e-09 1 20.4% 3:159 28:205 --EWVVIHTNPKCETRARDGLLGAGLLAFLPMEQIERRHGRGRKvvIRPMFPRYLFAGMDVKkqSVDQIRACDGVKGVLSFDKTGAVARVAVSDLIKILedGQMADVARLKEGAVVKLVKGSWCGQDLTVTGYdaKERVIGELTGSAMRLAVTAPLDAV---
338 UniRef50_C6A1F2 NusG transcription antiterm... 63 2e-09 1 16.7% 5:160 10:147 ----FAVRVTVGQEENTAKLIYSKAKTYSLPIMAILSPSK----------VRGYIFVEATEKAAVDEVIRGIRHAKGTL-----PGPISFIEIEHFL----EEKPAVSGFEPGDIVELIAGPFKGEKAKVVRVDESKD-EIVVELIgvPIPVTVRGEYVR--
339 UniRef50_Q94AA3 AT3g09210/F3L24_8 n=6 Tax=r... 63 3e-09 1 13.5% 3:106 97:217 --QWWAVRVSrgHerALARQFPEMEFTVYAPSVQVKRkkNGSISVKPKPVFPGCIFIRCILNKEIHDSIRDVDGVGGFIGSknKPRPVDDSDLEAIFKQAKEAQEK--------------------------------------------------------
340 UniRef50_D1PI13 Putative transcription term... 63 4e-09 1 13.1% 4:140 50:198 ---WYVAVVRVNCETRIADSIRINlfDYWIPKVKVVykRSNKRKVKEKLFLSTFIFCNVSPRQLDKIRFRSDVYKMLTMPGQRKIYQIPDQVVANYRYFVENDEEppVPLKKGIKVRVVAGSMKGVEAYVQSYNGKKAVI----------------------
341 UniRef50_Q8EUN7 Transcription antiterminati... 63 5e-09 1 19.4% 3:105 19:161 --KWYIVTSINGNEDTVYKNIEDKviEVFDPiiTWETLPGGRYkiREINRFPGYIYIKMIMEDDAWYVIRNTFGVTGFVGSSgkPIPMSDIEVANLFNPEMNQDI---------------------------------------------------------
342 UniRef50_C7DH82 NusG antitermination factor... 63 5e-09 1 18.7% 5:154 3:132 ----FVVKVTSGQENIAANILQSKLSKGDAPIYSIIVIEG----------LRGYIIVEAQDELACRNFITKERSIKGII-----PKPMDPADVEKLIATKSTAQ----DISRNDIVEFTSGPFKGYKAKVLKVD-ELKSDITVELMDVVVPIPI--------
343 UniRef50_Q6VE90 Orf37 n=2 Tax=Pseudomonas s... 63 5e-09 1 21.7% 1:152 1:153 MSNWYLINHNPKAVQGIIFRIRALGAevYSPANLKITKRLDcvRTSETQLFPGYLFVKLNPEVLHTSIVLQVSGVKKFVSFGGVLATISDCLIEAIKSSLLVRVDKKVTQIECRGVQ--PELLVQLESITLIRSSLDRQAALFKLLQEESRI----------
344 UniRef50_Q2NEV9 Putative transcription anti... 62 6e-09 1 16.7% 5:160 3:140 ----YAMRVLIGQEKNVASLLAQ----------SVKHEDTGISAILSPESMKGYIFVESDKTLDMRHPALKVPNLRGLVEGD-----VDFDELKSFLSP----DQSIVNIEKGSIVELTSGPFKDEKAKVVRIDEAKE-DVVLELIEAAvpVTVKGDQIR--
345 UniRef50_Q8ABS3 Putative transcriptional re... 62 6e-09 1 11.2% 3:162 40:221 --SWCYLFIHHAKVETVSKKLQTEQYRIFVHKSIVYKRGNKRIKKEEQATISGLVFIQGDANRIQKFLKENFFNLYLvdCSTGEIAAIPDSVMQPFMrrIRFMPHSFDYYSVGnlVRITSGILSGLEGYRIRISRDKCLVTSIGGMTVAiyVRLRRKQLEKI
346 UniRef50_B3T614 Putative KOW motif protein ... 62 6e-09 1 15.4% 5:160 87:224 ----FAVRTTGGQEKIVMRLLEARI---------KMEKINIQSVLLLSDL-KGYVVVEARDVSAMFDAIQGIRHIRGQLRGE-----LTYKEIDKYLIKKS----TVSELAVENTVEIIGGPFKGMKATIteLEKEEATVILLDA-TYELPVTVDANYLK--
347 UniRef50_Q6L1X2 Hypothetical transcription ... 62 8e-09 1 16.6% 6:162 133:282 -----IAKCTIGKELDTAVDLSAKA-ETDLKERLISNkrNEILSIMSPYEIKGYIFIETMHVDRVEYLARTLRNFKGIISGT-----VSMDEIEHYLTP----KPAVSGLSLGDLVEIVGGPFKGERAKIMSIDASkeVTVQLTESMVPIPVTVKAESIRPL
348 UniRef50_A9SPI1 Predicted protein n=1 Tax=P... 62 8e-09 1 18.1% 4:158 119:326 ---WYMVSTPKKAEHEAAEQLHIqkYEVLTPSIPSFRkkSGRYSDSRVRLYPGCLLIRCVMNRDVYNMIRSNLRIYNFFGTKAqpSAVSIIEIEELFRKMEEAepPPPTIEKGALIRINVGPFINHTGIVNYVDHeeTVQLSVVIFGQSTDAELRIDE----
349 UniRef50_Q11LV0 Putative uncharacterized pr... 61 1e-08 1 13.1% 2:146 1:181 -MTWYAIRTVPGAQkaVERALSEAGYVHYMPAERRlrKHTDLWKARRFAMLVGYVFVKGPVD---FRALEPVPGVHSIVGICGRPMEIDLLDILTLRSMeaEEKFDRDARVARKTIRIKSKKDARLKKIVEKLERADDLVVSLDVV----------------
350 UniRef50_C6JAQ8 Putative uncharacterized pr... 61 2e-08 1 14.0% 69:161 5:100 --------------------------------------------------------------------LRKVIGLTKLIGTGDEIVPLVQEEIDLLMKIGTDKQLVEMsiIENDRVQILAGPLMGMEGNIRRIDRHKRTalEIEMFGRTVEMKGGLEIIRK-
351 UniRef50_A8UUU2 Transcription antiterminati... 60 2e-08 1 18.6% 4:159 2:195 ---WYVLKVRSGKEEALKELLG-RDFEVLYPSRKKLNvvNGKKRYSfeSPLRGYLFVKGRYEDIL-SKTENLLDVVGFLIMGGKVRTLTDEEVSDLQKRVEKGERLKTLLPERgrVKVVSGEWTGAEGVIEEVYEDLSLKLKLRLWDKTFTAILPLERV---
352 UniRef50_Q74M56 NEQ540 n=1 Tax=Nanoarchaeum... 60 2e-08 1 13.5% 5:160 18:155 ----WIVKTAGGKEEIVADLIEAKA----------KKLGANVYSIVIAPGIKGYIFVEADKYDTVNELVHDIKHVRKVL-----PKPIEVKDIEKFIKAE----PLVTKVNVGDIVEVIAGPLKGSRGKVVAFN-ENTGEVTIETLDSVipVTVSIHDIK--
353 UniRef50_B7KSX1 Putative uncharacterized pr... 60 2e-08 1 12.6% 3:161 46:236 --KWYVCTTAPSRELSAAASVRQapFAAYVPCEFFWHRAIRsrREIQRPILRHYILVglAALRDRDREGRNVHGLAGILGAPggPLAMNGEGLRWLRAQGEDEIAGATniQPGEDVRAGSGVFSGFLGKFIGTAEGGTvvIALDMRSTSCEVRLPIEDVHR-
354 UniRef50_O27714 Transcription termination f... 60 3e-08 1 16.7% 5:160 19:162 ----YALKTSVGQEKNVARMLARKVRDSGI----------EINAILVPESLRGYILVESSSKIDMRNPAIRVPHLRGVVEstEGEAEIDFEEVKRFLKPE----PIISSIKKGSIVELISGPFKGERAKVIRID-ESREEVVLELIEAAvpVTVKGDQIR--
355 UniRef50_B8IRQ9 Putative uncharacterized pr... 60 3e-08 1 15.8% 3:97 56:148 --RWHAAVTFPGCEVKVRDAMQLRRIDTVLPMVRFWRIRSRKRFVAERPLLARTVIFGLDHACQDIAGIEGLERVVR--GASVGWADLPEQDVYDLR-----------------------------------------------------------------
356 UniRef50_Q8TX53 Transcription antiterminato... 60 3e-08 1 17.9% 5:160 10:154 ----YAVRVQAGREEATADMLVMRARR----KVKEEGIETGLKAVIAPEELRGYVIIEVelTDELRDLIHDLPDTRGIVE-----KPMDFEEIEHYFAPKPEAVE----ISEGDVVEILSGPFKGEKARVVSVDESRR-EITVELLEAPvpVTVKMDALR--
357 UniRef50_Q7NAK3 NusG n=2 Tax=Mycoplasma gal... 59 4e-08 1 11.6% 3:140 9:188 --QWYIATTTNGNEDSVIKTLKAkiFDSNNPTHNIPATMRnkYKITDTNKYPGYIYIKMEMNEAAWFAVRNTVNITGIVGSSgkPIPISSSEELDLLNGESFDQNYRIVITPNAIIEMDRNLFNERGELILDENAAKTIV----------------------
358 UniRef50_D2MG88 Putative uncharacterized pr... 59 4e-08 1 17.1% 17:162 25:186 ----------------VRRLQDELGLAPYLPMEWKSVAarGRRREVQVPLLIGYLLLPEalAHGRYGDVLATRGVRGLLHYAGspARLSDATVERLRAEERAADNKRQmwQPGDEVWAEILPGRSLLARIseKAPRGRIAILleVLGRR-AFAVEPKQLQRV
359 UniRef50_D1JE94 Putative transcription anti... 59 6e-08 1 13.5% 5:160 5:145 ----YAVKTTVNQELAVATMVEGALGE-------EGVKDHGIKAIMVPEELKGYLLVEASFPEALEQIIQSIPHARGLVKG-----VMGLEEVEHFLTP----KPSVTGILEGSIIEIVSGPFKGERARVKKVDehEEITIELFEAMVPIPVTVRGDSVR--
360 UniRef50_A3AP86 Putative uncharacterized pr... 59 6e-08 1 16.5% 30:162 267:388 -----------------------------IPVEEVESIIREEKEEQERV-------------DREFEEMEN----GGIVESFNKPVEDSekIKRQFKKPISKGGSNHNAFTPGASVHVLSGPFEGFTGSLLEVNRkkKATLQLTLFGKESFVDLDFDQIEAV
361 UniRef50_Q57818 Putative transcription anti... 58 1e-07 1 17.3% 5:160 3:140 ----FAVRTMVGQEKNIAGLMASRA----------EKEQLDVYSILASESLKGYVLVEAETKGDVEELIKGMPRVRGIV-----PGTIAIEEIEPLLTPKKIIE----NIEKGDVVEIIAGPFKGERAKVIRVDKHkeVTLELENAAVPIPITLPVEGVK--
362 UniRef50_UPI00016B21AA transcription antiterminati... 58 1e-07 1 13.6% 97:162 9:75 ------------------------------------------------------------------------------------------------KRMGVEEPKHQIDFEEGEVVSVIDGPFKGFDGTISEIDtkGKIKVMVSMFGRDTPVELDALQVKKI
363 UniRef50_UPI00003C8438 transcription antiterminati... 58 1e-07 1 18.1% 6:160 146:293 -----IAKCTIGKELDIAIDLSNHAERD---REERMAMNKNARNEVMAVMSpgYFFIETMHADRVDVLSKSIRGFRGFVSGD-----IDISEIEKYLTP----KPAVTGLEMGSLVEIVEGPFKGERAKITAIdaKEEVTVQLIESMVPIPVTVKAEAIR--
364 UniRef50_UPI0001BCE1C5 transcription antiterminati... 57 2e-07 1 23.1% 3:67 4:77 --KWYAIQTYAGSEMSVKRAIENLVveVVVPTEDVIEIKNGKQKINEESLYPGYAFAPFRSRHITFA-----------------------------------------------------------------------------------------------
365 UniRef50_Q12UQ1 LSU ribosomal protein L26e ... 57 2e-07 1 12.7% 5:154 8:137 ----FVVKTTANQERSVAAMLAQ----------VAKKENLDIRSIIAPDELKGYVLLESSDSGAVEQAIQTVPHARTVVKGQSTIA-----EIEHFLTP----KPTVTGIVEGAIIEVTSGPFKGEKARVKRVD-EGHEEITVELFDAVVPIPI--------
366 UniRef50_C5SIV6 Putative uncharacterized pr... 57 3e-07 1 15.4% 2:157 21:173 -RAWLIVTTYAKKEAVVLSQLKGIGYEGYRPMIAKRRKIAGQEAPVLVplYPNYVFVRALEG----RSPLSLFGLQGLACVHER--AVLDAVVQAHRAKEADgkNEGKAFRRGDRIKTLGGLL---EVVLSDPIDTNRCAALSSFMNGSSRLIVGLD-----
367 UniRef50_D2EF56 NusG antitermination factor... 56 4e-07 1 14.7% 3:158 11:145 --HFFIIRVTIGREMQALERLQSQ-----------LARVNGIYSIVKPYSLKGYIIVEADSRESISNLIYNIKHIRGIMN-----KELSKDEA----LKTIEKKKQNIDINIGDVVKVLSGPFKGETATVKAVNKEKE-ELTVMFLESAVPINVNIKI----
368 UniRef50_B5IAH1 NusG antitermination factor... 56 5e-07 1 14.8% 6:154 133:262 -----AVKTTIGQEVKVARDIG---------MKAKIHGWKEIFSVLAPYNLKGYVFVETSRPDKVLSLIRGIKDAKGVVRGE-----MHLEEIKHYLTPTPTIHR----ISVGDIVELVEGPFKGEHAKVIQIDEAKD-EITVELFEAMVPIPI--------
369 UniRef50_P36262 Transcription antiterminati... 56 5e-07 1 16.9% 104:162 10:69 -------------------------------------------------------------------------------------------------------PVSSVFFEVGERVCVSDGPFASFNGIVKNVDEEkrVHVEVVIFGRVTPVELAYNQVEKI
370 UniRef50_Q978E9 Transcription termination-a... 56 6e-07 1 18.1% 6:160 138:285 -----ALKTTVGSEVQVATDLNNKA------ERDRDERSQGGEKQPSEVfiKGYIFVETMHPDRISYLAKDIRGYKGMVSGK-----IDLEEIAHYLTP----KPAVSGLELGSLVELVEGPFKGEKAKIISIDskEEVTVQLVESMVPIPVTVKAESIR--
371 UniRef50_Q9Y9W3 Putative transcription anti... 55 9e-07 1 15.0% 3:162 8:149 --RFYAILVTSGAEVNVATIIAERARALGL----------DIRSIIVPPRIKGYVILEAHDPGDVYDATRGLRHVKR-----RRPLILKFEEVMKLVKPEVEIPA----LKPGQVVEIVAGAFKGMKARVIDVNQSKG-QVTVSLLefRATATIPIDEVRPV
372 UniRef50_B0NND0 Putative uncharacterized pr... 55 1e-06 1 18.8% 4:72 16:84 ---WCIVLTAPHAELNIQKKLEQQGFITYVPTISVRRSWAGCIKEIHIPTIARCVFVYATKEEMQEMQKEYT------------------------------------------------------------------------------------------
373 UniRef50_Q54017 AnfA1 n=2 Tax=Serratia ento... 54 2e-06 1 28.9% 2:98 3:109 -KKWYLIRCNYGKIDLGQKSLETYgfEGfaPNLKPSLEFEGFYLTFQKNFfpPYLFVRFDIDHIPISKIQHAIGVKGFVRFGGGIKSIPDIVIGKIMK----------------------------------------------------------------
374 UniRef50_Q48B18 Transcriptional regulator n... 53 3e-06 1 34.5% 1:84 73:158 MKNWRVLMHNSSVYQSLITSIERLDVEVYSPESITYRKRPDRPSSVETklFPGYLLLRFDPEVTHTTTITALNGARGFVQFGGQ------------------------------------------------------------------------------
375 UniRef50_B3C5U6 Putative uncharacterized pr... 52 6e-06 1 14.7% 2:69 14:81 -RNWYIVLTSPWKEKKIREDLDNKGIISHLPTTYVQYKWKEKIRKIQIPTVNRCIFIYATDSEIKTLRV---------------------------------------------------------------------------------------------
376 UniRef50_Q4WP96 Transcription elongation fa... 52 7e-06 1 17.5% 7:143 246:371 ------VRCKAGKEREV----------VFAIQKRIEERPPGSRKPIRIiaMSGYIYVEARRQADVMEALEDMSNVY----PRTKMILVPVREMPDLLRVQKSEE-----LNPGGWVRIKRGKYQGDLAQIEEVDTNgdVTVRL-------------------
377 UniRef50_B8BT45 Predicted protein n=1 Tax=T... 51 8e-06 1 16.2% 3:162 79:276 --QWYLINCVAGIELdaQARLVTKDFpiVVPVERHLRSHGDKKKVVDVkrYPGYVFCKIRLTEDVyrSWMGTVNRKGHKKLPPAPLPLPDEEVKKFKGLEEKQELFEDMfeVGQMVKVLSGNFEGEDGTVRRL-KDGQICVRMFTYGQTFDNWFDPTAIRPL
378 UniRef50_UPI000197ADA0 hypothetical protein BACCOP... 51 1e-05 1 12.2% 3:150 39:191 --SWCYLFVHHAKVETINEKLILK-FKTFIHKSIAYKRGKSHVRKTERPTISGLIFIQGNSREIQNYLNQIAFDLYLvdCSTKKTAIIPDRVMQPFMQLSQINPHHIRFMPHstLIKITSGVLTGMEGYCIRIARDK---CLVTTVGNMT------------
379 UniRef50_A0RUG2 Ribosomal protein L24A n=1 ... 51 2e-05 1 19.1% 51:160 26:127 --------------------------------------------------LKGYVVVEANDPNAAYQATDGVRHIKGQLRGE-----LDFKDIEGYLVKKS----TVTSLEKDQTVEITGGPFKGMKASITRIDHEkaTVVLLDA-SYQLPVTVDANYLQ--
380 UniRef50_A4RYW5 Predicted protein n=2 Tax=O... 50 3e-05 1 16.1% 4:158 28:258 ---WYMLEVPETRENQAKAAILALnvVAWVPRvyVAEEDAVGKSELeeMLQPGYVLVRCALTQELMDAFDDLRSVRGFATGGSspVVKTEADIEAEKAREQAKEVMRAERGDedRVEVHTGPFKGFKGHIVARNDDGSVEATLAIFGRDTNVSLAADE----
381 UniRef50_B1L6L1 NusG antitermination factor... 50 4e-05 1 21.8% 5:146 9:131 ----FPVRVISGKEINIMRLL----------VSRVSSTGAKVRSIIFVPKFKNYLFVEAEREYEVRKLIAGLSKLRL-----ASSSPVPPQEIEDILSSETAGME----IEPGDIVKIIKGNFKGYRAVVIATPEGKSKMLTLKLL----------------
382 UniRef50_C1FFC9 Predicted protein n=1 Tax=M... 49 5e-05 1 18.4% 87:162 513:591 --------------------------------------------------------------------------------------PIVGEEAMALRDAAIRPGAATATGAGAASIEVVAGPFKGFKGYVtkPRGDGAVDAKLVIFGRETDVTLEAGEFETL
383 UniRef50_Q92W20 Putative uncharacterized pr... 49 5e-05 1 14.3% 14:90 2:79 -------------ESIIERNCRKDGFDIFMPSFYTELRHHRTKQILQkpFLVGYGFVSLPR--LNFEELRRVDGVVCFLRGAngPLEFPD------------------------------------------------------------------------
384 UniRef50_C2HWG3 Transcriptional activator R... 49 5e-05 1 29.7% 97:160 65:128 ------------------------------------------------------------------------------------------------LDCEQLKHATKQLPEKGQTVRVARGQFAGIEAIYLEPDGDTRSIMLVKMISQQVPMSIENTDWE--
385 UniRef50_B8I2J4 NusG antitermination factor... 48 9e-05 1 16.4% 1:73 1:77 MNNWFVFRVQIGEEYKACEFlkEESVE-FVPQVEVVTKNSQSIRKELTPTFPGYVFTGSILKEKTFVDLAYLY-----------------------------------------------------------------------------------------
386 UniRef50_A3TRT6 Putative secreted protein n... 48 9e-05 1 21.3% 85:159 361:434 ------------------------------------------------------------------------------------PVPLPK--ITATPLPSTTVAVDPDPFSPGDTVKITAGQYLGLSAKVLKVDtkNTVTVEVVVLGIKLPVVLPYSSV---
387 UniRef50_B5JIS7 Putative uncharacterized pr... 48 1e-04 1 18.9% 86:159 1:78 -------------------------------------------------------------------------------------MVVEDEVVDLIKENSEdsPAVDDSFQCGENVEVLEGPFQGMMGTVLqlNEGSRVAILLTLLTSETKVTISRSHL---
388 UniRef50_P75049 Protein MG054 homolog n=2 T... 48 1e-04 1 14.9% 42:128 84:168 -----------------------------------------KVKISEKNLLGRYIYIKMIYSEDAWRIIRNFPGITGIVGSSGrpTPLDQADADNLEQMLKG-----ISVNPKKRVLVTNTAIVEMDA----------------------------------
389 UniRef50_B5HX00 Putative uncharacterized pr... 48 1e-04 1 22.0% 108:157 4:54 -----------------------------------------------------------------------------------------------------------PDIAVGASVTITDGPFATLRATVTEIdpSQKVKGVIELFGRHAPVELSFT-----
390 UniRef50_B8ICP2 NusG antitermination factor... 48 1e-04 1 23.3% 2:61 38:97 -RRWYVVRIDPTRERKIREGLETAGFATCVPASSAVIEHRGRYRETRRRAVPGYLFVGADR-----------------------------------------------------------------------------------------------------
391 UniRef50_UPI0000382CEE COG0250: Transcription anti... 47 3e-04 1 16.7% 101:160 1:61 ----------------------------------------------------------------------------------------------------EVQDFVETLFAIGDEVRITDGGFATFMAKVEKVdkRGRYTVAVDVFGRPVPFEIAEESLE--
392 UniRef50_A7VAG7 Putative uncharacterized pr... 45 6e-04 1 16.1% 4:65 16:77 ---WNIVLTGQHAEPRTKAMLEAKGIITWLPLAPVRRQWGRILKEIHTPVIPRCVFVYISNEERN-------------------------------------------------------------------------------------------------
393 UniRef50_D1PC69 Putative uncharacterized pr... 49 6e-05 1 11.1% 4:138 2:183 ---WFIVKTDVFSEQQSIDFLREkiTDFYFPlrKTYKNENGEVKVRFVPVLQGMFFIRV-QNERRLKKVLSPYGYFMYKGFEMEpsKIPDEDMETFVYFNDreKRYSDLVKENDTIRILSGPLAGRVGVVKQIKHKGK------------------------
394 UniRef50_Q6BZG0 Transcription elongation fa... 46 5e-04 1 15.0% 5:137 249:367 ----YAIRCTPGREKDLVRKLYEKK------RTLARSNPLEILTVFQRDSFKGYIYIEAKKPEAIERALTGMVNIY-----AKQRLLVPVREYPDLLKQVKSSDVE---IVPGIYVRITRGKYKNDLAIVDNLSENG-------------------------
395 UniRef50_UPI0001743F0E transcription antiterminati... 45 0.001 1 20.8% 2:25 16:39 -KKWYIIHTYSGYEKKVAADLEKRI-----------------------------------------------------------------------------------------------------------------------------------------
396 UniRef50_A8ABQ4 NGN domain protein n=1 Tax=... 45 0.001 1 13.3% 5:162 6:145 ----FPVRTVSGREIDVALLIEERARA----------KNLDVKSVIVPPRIKGFVIVESP---AHFVVAEAVRGIKYVRGGPGK--KISLEEVLKMIKP----VPIIETVEVGDIVELVAGVFKGVKARVekIPEKNELVLSIVEAAYPLQITVPADYVRPV
397 UniRef50_D2VQ68 Predicted protein n=1 Tax=N... 44 0.001 1 13.6% 5:144 125:259 ----FLVKCKQGKEKEAVMTLLQKHFSV------KHSPNKKDRLLITSAlfKGKIYIEAQKEVHVRHAIEGLSHLI----YESGIKLVPLKEMPDVLNVNQLSTKIQD-ISVGKWVRVKRGTYKGDIGKVHDVDKARgvVVLVP------------------
398 UniRef50_P27692 Transcription elongation fa... 44 0.002 1 14.3% 7:146 290:417 ------VRCRPGKEKELIRKLLKKKFN--------LDRAMGKKKLkqRDNYTGRIYIEAPKQSVIEKFCNGVPDIYI-----SQKLLIPVQELPLLLKPNKSDDVA---LEEGSYVRIKRGIYKGDLAMVDQIS-ENNLEVMLKIV----------------
399 UniRef50_C1N286 Predicted protein n=1 Tax=M... 43 0.003 1 20.9% 116:158 422:464 -------------------------------------------------------------------------------------------------------------------IEVQEGPFKGFKGYITGNNTNGSVEARLLIFGRETSVTLAADE----
400 UniRef50_A8HQJ4 Global transcription factor... 43 0.004 1 18.3% 2:143 170:299 -KLW-LVTCKVGHEREAVVQLLQK---CYTMAERGTPLR--IMSAVALDHLPGFIYVEAAKESHVMDAIRGLRTVY--IGRGAKLVPLNE-----MVDAVTVNKKAKDDMARDTWVRVRSGLYKDDLARVVEVDsaGRAVVKL-------------------
401 UniRef50_O80770 Putative transcription elon... 43 0.005 1 17.6% 2:143 170:295 -KLW-LVKCAIGREREVAVCLMQKIVD-----------RGSEFKIRSAIalQNYVYIEADMEAHVKEAIKGMRNIY----ANQKILLVPIKEMTAVLSVESKAI----DLSRDSWVRMKLGIYKGDLAQVVDVDnrKRVTVKL-------------------
402 UniRef50_Q01WX6 Putative uncharacterized pr... 42 0.006 1 20.0% 110:159 27:76 -------------------------------------------------------------------------------------------------------------PRAGQRVRIKGGALAGVEGVVIGFRQSLRLILSITLLQRSVLLEIDRRLV---
403 UniRef50_C6J5U5 Predicted protein n=1 Tax=P... 42 0.007 1 9.9% 5:115 5:136 ----FAIQVMTGKENNVKKLMenESAQNWIKAVHTFTTTTRRlkEIKRAIMPGYIFIEmhLPADVWHLIKSIPGVIKQ--FTGSGQVIGAEEFQKMLGLEPEEQQVEVAVPIQEQ-----------------------------------------------
404 UniRef50_A6L4G6 Putative uncharacterized pr... 41 0.009 1 17.0% 53:140 159:255 ----------------------------------------------------GYLFVCAPLDELNLILAHLFPRQyaKDRNSYSVAVIPHRQMEEFinIELMDKPLEEYIQKKQKIRITGGVFQGKEGCIMRLHRNTKLV----------------------
405 UniRef50_A4RZ64 Predicted protein n=2 Tax=O... 40 0.024 1 31.2% 110:141 319:350 -------------------------------------------------------------------------------------------------------------FMPGDQVIIVEGDLRNLEGVVERIDPDGRVVV---------------------
406 UniRef50_Q6MDM7 Putative transcription anti... 40 0.026 1 17.5% 1:40 1:49 MYKWYVVQVLSTHEKKVKKALEEhiEQILLPTENVSEVKK--------------------------------------------------------------------------------------------------------------------------
407 UniRef50_A7IAL6 Ribosomal protein L24 n=17 ... 40 0.028 1 13.5% 5:160 26:166 ----FAIKTTSKQERTVADNILKAI-ETKATDIKVTSI-------IVPNELQGYVLVETPEERNRIEQLVEMIAHARAVAKGQT----TLAEVGHFLIP----KPVVSGIDEGTIVELIAGPFKGEKAVVKRVdaKEEITVELYESVVPIPITVRGDNVR--
408 UniRef50_A8MDC8 Transcription termination a... 40 0.036 1 14.9% 7:160 11:149 ------VRVIAGQEYNVAAIIRTR----LELMEKDKRKYYNVPSIVVPPNVQGQVYLETPH---SYVAIDLSTGIKQYRGLMMGKVPLTE---------LMKMIKREIKVQINDVVEIITEPFRGFKAKVVDVDEKNNTVKLL-LFDTAtpVTLPIKSIR--
409 UniRef50_D0T981 Transcriptional regulator U... 39 0.052 1 13.4% 80:146 17:90 -------------------------------------------------------------------------------GGRSYFPYLSDREMETLRWVAASYSNELPVYVPddRVRITSGPFADMEAEVVVQPGGGHKDVMVRIL----------------
410 UniRef50_B0EU05 Suppressor of ty, putative ... 39 0.055 1 12.9% 5:143 119:240 ----FAIRCKQGYEKDICMRikDRifSVFVPKEKT-----------------GIVYIEA-MTERKFAD--ACDGVRDLYINT--IHALNDKQIEELL-----VSRMPTTIEPNSYVRINAEPYKGDLGVVVETTENKKVIVKL-------------------
411 UniRef50_UPI00016C0B0F transcription antiterminati... 39 0.057 1 16.7% 3:44 5:55 --KWYVVHTYSGYENKVkrNMQELIQKVEIPMHNEEEEKNGTTR----------------------------------------------------------------------------------------------------------------------
412 UniRef50_A6UJ02 Putative uncharacterized pr... 39 0.062 1 10.6% 1:47 51:102 MKrwYPIRVAPGyeSIIERNCRKDGFDIFMPSFYTELRHHRTKQISR-------------------------------------------------------------------------------------------------------------------
413 UniRef50_C4LVU5 Transcription initiation fa... 38 0.091 1 12.9% 5:143 119:240 ----FAIRCKQGYEKDICMRIMkhLFSVFVPKEKT-----------------GIVYIEA-MTERKFAD--ACDGVRDLYINT--IHALNDKQIEELL-----VSRMPTTIEPNSYVRINAEPYKGDLGVVVETTENKKVIVKL-------------------
consensus/100% ..................................................................................................................................................................
consensus/90% ......h....t....h...h...................t.........h.thlhh...........h.....h............h....h..h................tt.h.h.tt.h.t..s.h..........h.h...................
consensus/80% ..Wahh.s..t.c..h.t.ltt..ht.hhP.......httth......hh.shlhlph...t.....h.th.thhthht.tt....l..t.ht.hh...t........h..sp.l.lhtGshts..u.h.thp.ptphhh.lthht....h.h........
consensus/70% ..Wahlpshst.EppstptlppthhphhhPh.thhphhtsphphh...hhsuYlhlphthppt.h.hlpph.tlhthlt.stp.h.lstpphpthht..t.t......ht.GphVplhpGshtshpuhl.phptppphhl.lphhst.h.hpl....l...
|
MView 1.51.1, Copyright © 1997-2009 Nigel P. Brown